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ABSTRACT 
Infectious disease is a significant health concern. The transmissible nature of these 
diseases as well as developing issues such as antimicrobial resistances provide a unique 
challenge to public health and can have significant and potentially unpredictable impacts to the 
world economy. Combatting and preventing potential pandemics require a multifaceted approach 
including the development of new antimicrobials and vaccines as well as in further 
understanding the interactions between pathogens and hosts. 
 Reported here are studies that investigated infectious diseases from two separate aspects 
using nuclear magnetic resonance (NMR) spectroscopy. The first aspect investigated the 
structures of homologous membrane localization domains (MLD) of two different bacterial 
toxins. The MLDs studied were from the C-terminal domain of the AB toxin Pasteurella 
multocida toxin (PMT), which is expressed by Pasteurella multocida, and the Ras/Rap1-specific 
endopeptidase domain of the multifunctional autoprocessing repeats-in-toxins (MARTX) toxin 
expressed by Vibrio vulnificus. The function of these MLDs is to localize the toxin to 
membranes, which aid in the targeting of the catalytic domains. The study reveals that these two 
toxins form 4-helix-bundle motifs in solution, consistent with X-ray crystal structures of 
homologous bacterial toxin constructs. 
The second set of studies addresses the antifungal drug amphotericin B (AmB). AmB is a 
natural product expressed by Streptomyces nodosus and has been used for over fifty years as an 
antifungal drug. Through its long use, it has evaded antimicrobial resistance. However, because 
of its high toxicity to humans, it has only been used in life threatening infections. We first 
developed a protocol to express and purify large quantities of isotopically 13C-labeled AmB 
through biosynthesis for solid-state NMR (SSNMR) experiments. Purified materials were 
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prepared for SSNMR experiments, where the secondary and tertiary structure of the aggregated 
for of AmB was studied. These studies will contribute to efforts to develop a structure-based 
understanding of AmB function, and ultimately to new analogs of AmB that have an improved 
therapeutic index (ratio of potency to toxicity). 
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CHAPTER 1 
Introduction 
 
1.1 Preface 
 Infectious diseases remain a significant concern with regards to public health and the 
global economy.1-3 Despite a continuing decline in reported cases, infectious diseases are 
responsible for killing over 6 million people annually and are expected to have severe economic 
effects such as a decline in the world’s gross domestic product.2 Unlike many other illnesses, 
infectious diseases are unique in various ways, such as their transmissible nature.4 Despite 
significant advancements, such as the development of antibiotics and vaccines as well as 
improved hygiene practices, many issues continue to plague this area of public health. 
 Treatment of infectious diseases are greatly complicated by the increase of antimicrobial 
resistances as well as the emergence of new pathogens, which can have an unpredictable impact 
on a global level.4 Advancement in treatment and control of various infectious diseases require 
not only the development of new antibiotics and vaccines, but also require the mechanistic 
understanding of how pharmaceuticals work in order to increase their therapeutic indices. 
Furthermore, better knowledge of pathogens and the ways in which pathogens interact with hosts 
and other environmental conditions will provide greater opportunities to treat illnesses.2,3,5  
Studies on two different aspects of infectious diseases were investigated using nuclear 
magnetic resonance spectroscopy (NMR). The first aspect, reported in Chapter 2, is a solution 
NMR spectroscopy structural study of homologous membrane localization domains in two 
bacterial protein toxins. Bacterial toxins are a class of virulence factors expressed by bacteria to 
aid survival within a host and are often the causes for disease symptoms in hosts.6,7 Thus, 
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structural information regarding bacterial toxins can potentially aid in the development of new 
antitoxin therapeutics.8-12 
The second aspect, reported in Chapters 3, 4, 5, and 6 relate to solid-state NMR 
spectroscopy (SSNMR) studies of the antifungal drug amphotericin B (AmB). Despite the long 
use as an antifungal drug, AmB continues to be one of the most potent drugs in treating life-
threatening infections.13 Unfortunately, the dose limiting toxicity of AmB limits its use.14 
Structural studies of AmB will lead towards the development of new analogs of AmB that have 
equivalent potency but decreased toxicity. Finally, Chapter 7 describes the development of a 
device used to pack samples into SSNMR spectroscopy rotors, which has enabled some of the 
NMR studies reported here. 
 
1.2 Bacterial toxins and membrane localization domains 
1.2.1 Bacterial toxins 
 Pathogenic bacteria have many virulence factors, which are ways in which bacteria alter 
host-microbe interactions allowing microbes the ability to circumvent the host’s immune system 
and colonize.15,16 Strategies include biofilm formation, iron acquisition, and the production of 
bacterial toxins. Bacterial toxins are molecules excreted by bacteria that range in sizes from 
small molecules to large proteins that harm the host for the advantage of the microbe.6 
Toxins are often the causative agent of disease as is the case for diseases such as 
botulism, cholera, tetanus, and whooping cough.6,7 Treatment and prevention for many toxin-
mediated diseases have relied upon the targeting of toxins. For example, toxoid vaccines, or 
vaccines made of inactive toxins, have been used to successfully prevent diphtheria and tetanus.7 
Targeting of toxins has been shown to be a successful method for the control of bacterial 
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infection diseases,6-12 and continue to be an appealing target for the development of new 
therapeutics. 
1.2.2 Membrane localization domains 
In recent years, it has been discovered that many protein toxins have a membrane 
localization domain (MLD).17 The function of the MLD is to bind to membranes in host cells and 
aid in directing the catalytic domains of the toxins to their membrane-bound targets. MLDs vary 
in size, amino acid type, and structure. Some MLDs are short, hydrophobic domains while other 
MLDs are larger four-helix-bundle motifs (4HB).17 Moreover, MLDs have been found in a 
number of different types of toxins and have been found in both the termini of the proteins as 
well as in the center. 
A group of single-chain protein bacterial toxins were discovered to contain homologous 
4HB MLDs.18-21 These domains were found in PMT-like toxins, RTX effectors, and clostridial 
glycosylating toxins.4,20,22,23 Previously, a subset of 4HB MLD was demonstrated to bind to 
membranes containing negatively charged phospholipids.18 However, the mechanism of MLD 
membrane association and the accompanying conformational and structural changes are not well 
understood. 
1.2.3 Pasteurella multocida toxin and Vibrio vulnificus Ras/Rap1-specific endopeptidase 
 Pasteurella multocida is a zoonotic Gram-negative human pathogen causing significant 
diseases such as pasteurellosis, pneumonia, and septicemia.24 One of the major virulence factors 
of P. multocida is its production of Pasteurella multocida toxin (PMT).25 PMT is a 150-kDa 
(1285 amino acid) heterotrimeric G-protein-deamidating AB toxin with a N-terminal domain 
(residues 1 to 568)26,27 responsible for receptor-binding and translocation and a C-terminal 
domain. The structure of the C-terminal domain was determined using X-ray crystallography and 
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revealed three subdomains: C1 (residues 569 to 719), C2 (residues 720 to 1104) and C3 (residues 
1105 to 1284).21  
 While a drastically different type of toxin, the C1-C2 domains of PMT have a high level 
of homology to the Ras and Rap1-specific endopeptidase toxin (RRSP, formerly known as 
VvDUF5) produced by Vibrio vulnificus.28,29 V. vulnificus is a Gram-negative pathogen often 
found in estuarine and coastal environments.30,31 Virulent strains of the bacterium have been 
known to cause severe infections that often leads to septicemia, where over 50% of infections 
leads to death. V. vulnificus has a number of virulence factors and is known to express a number 
of toxins as multifunctional autoprocessing repeats-in-toxins (MARTX) toxins.32,33 
 MARTX toxins are large, single-chained, heterogeneous groups of effector domains that 
are sandwiched between MARTX conserved domains.34,35 The conserved domains are embedded 
within the membrane of the target cells, inserting the effector domains into the cytosol. Within 
the cytosol, the conserved cysteine protease domain is activated by the inositol hexakisphosphate 
causing the cleavage and release of effector domains into the cytosol of the host cell. RRSP is an 
effector domain of MARTX, which was first discovered in the CMCP6 strain of V. vulnificus 
(UniProtKB: A0A0J9WYM4).28,29 
 The MLD of PMT (MLDPMT) is made of residues 589 to 668 (80 residues) in the C-
terminus and the MLD of RRSP (MLDRRSP; formerly called MLDVvDUF5) is the first 79 residues 
of the RRSP effector.29 In the sequences of these two proteins (Fig. 1.1), 27 of the residues are 
conserved between the two MLDs. To better understand the function of MLDs in general, the 
structures of MLDPMT and MLDRRSP were studied using solution-state NMR spectroscopy. 
Chapter 2 reports the solution structures of MLDPMT and MLDRRSP. 
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1.3 Amphotericin B 
1.3.1 Fungal infections and amphotericin B 
 Severe infections by pathogenic fungi, such as the commensal species Candida albicans 
and Aspergillus fumigatus, have a life-threatening impact on human health. Infections by certain 
fungi have mortality rates upwards of 90%, especially for immunocompromised 
individuals.36,37,38 Treatment of fungal infections varies with the severity of infection. 
Development of antifungals have been a significant challenge due to the limited amount of fungi 
specific drug targets and the emergence of new antimicrobial resistances.37 However, 
amphotericin B (AmB, Fig. 1.2a) has remained one of the most important treatment options for 
systemic fungal infections.13,39,40,41 AmB is a polyene macrolide that has been used for over 50 
years in treating life threatening fungal infections and unlike many antimicrobial drugs, AmB has 
evaded the formation of antimicrobial resistances.13 Unfortunately, AmB is also highly toxic to 
humans, limiting its use to only life-threatening situations.14 
1.3.2 Amphotericin B sterol sponge 
 Interactions between AmB and sterols, such as ergosterol (Erg, Fig. 1.2b), have been 
known to be an essential aspect of AmB activity. The long-standing hypothesized mode of action 
of AmB activity is described by the ion channel model (Fig. 1.2c).42,43 In this model, AmB binds 
to sterols and form ion channels in the plasma membrane, which allows for the permeabilization 
of the membrane leading to cell death. 
 Recently, a number of studies have shown that the ion channel model is at best 
incomplete and support the interpretation that Erg binding alone is sufficient to cause of cell 
death.44,45 Erg is the primary sterol found in fungal cells and is responsible for many functions of 
fungal cells, including endocytosis.46,47 Thus, binding Erg would prevent sterol-dependent 
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cellular function and lead to cell death. This has led to the development of the surface adsorption 
model (Fig 1.2d),45 in which it is proposed that AmB binds sterols at the surface of the plasma 
membrane. 
More recently, it was discovered that AmB forms a large, extramembranous aggregate 
that extracts sterols. This is known as the sterol sponge model (Fig. 1.2e).48 Magic-angle 
spinning (MAS) SSNMR along with other biophysical and biochemical methods, was used to 
develop the sterol sponge model. In this model, a large aggregate of AmB molecules forms on 
the surface of the plasma membrane and extract Erg. 
To further investigate this working model of AmB activity, the atomic-level structure of 
the AmB-Erg complex has been pursued. Chapter 3 discusses the improvements of isotopic 
expression and purification of AmB with 13C labels, which enabled our NMR studies. Chapter 4 
describes the heterogeneous nature of AmB and how sample preparation can alter the 
heterogeneity or homogeneity of the NMR samples. Chapter 5 reports some 1H NMR 
spectroscopy data that were collected on AmB and Chapter 6 reports initial studies to identify 
structural features of the AmB aggregate. 
 
1.4 NMR spectroscopy and rotor packing 
 NMR spectroscopy is a venerable analytical technique used for a variety of applications, 
including the study of molecular structure and dynamics as well as molecular interactions.49-51 In 
the studies presented here, both solution and solid-state NMR spectroscopy have been utilized. In 
the bacterial toxin studies, standard solution NMR spectroscopy pulse sequences were utilized to 
assign the chemical shifts of the proteins as well as to measure structural restrains necessary for 
determining the high resolution three-dimensional structure.52 
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For our AmB study, SSNMR was utilized, using pulse sequences such as DARR53,54 and 
SPC5.55 One of the aims of this study was to develop a better preparation of AmB SSNMR 
samples. In the new sample preparation method, samples are packed into MAS SSNMR rotors as 
a hydrated pellet to prevent non-uniform hydration of samples. This is critical since insufficient 
hydration is known to compromise spectral quality for protein microcrystals,56,57 and here we 
hypothesized that a similar effect would be observed in AmB. In the course of this study, one of 
the challenges encountered was the efficient transfer of precious hydrated samples into SSNMR 
rotors. 
Hydrated materials are technically challenging to pack into rotors by standard methods 
because of the pasty or gel-like nature of the sample, which often leads to significant sample loss 
due to interaction with the sample packing tools. To overcome these challenges, we have 
developed a series of rotor-packing devices (RPDs), presented in Chapter 7, that can efficiently 
pack hydrated samples into Chemagnetics or Varian Pencil style 1.6 mm, 3.2 mm standard, and 
3.2 mm limited speed MAS rotors.58 Using these devices, a hydrated sample that is pelleted in a 
200 µL ultracentrifuge tube can be efficiently transferred into the rotor using moderate speed 
centrifugation (Fig. 1.3). 
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1.5 Figures 
 
Fig. 1.1. Amino acid sequence of MLDPMT (top) and MLDRRSP (bottom). Conserved residues between the two 
proteins are colored in red. 
 
 
 
Fig. 1.2. Low-resolution structural model of Amphotericin B (a) and ergosterol (b) with a corresponding cartoon that 
is used in the remainder of the figure. In the long-standing ion channel model mechanism (c), AmB binds to Erg and 
forms ion channels in the plasma membrane, leading to cell leakage and cell death. Recent studies have found that 
the ion channel isn’t the primary active form of AmB. Instead, models such as the surface adsorption model (d), 
where AmB extracts Erg to the surface of the membrane, or the sterol sponge model (e), where AmB forms a large 
extramembranous aggregate that sequesters Erg from the membrane, have been developed. (Figure adapted from 
Anderson T. M., Clay M. C., et al. 2014 Nat Chem Biol 10, 400-406.)48 
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Fig. 1.3. A newly designed rotor-packing device can transfer hydrated SSNMR samples from 200 µL ultracentrifuge 
tubes into pencil-style SSNMR MAS rotors using moderate centrifugation. (Figure adapted from Hisao G. S., et al. 
2016 J Magn Reson 265, 172-176.)58 
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CHAPTER 2 
The membrane localization domains of two distinct bacterial toxins form a 4-helix bundle 
in solution 
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2.2 Abstract 
 Membrane localization domain (MLD) was first proposed for a 4-helix-bundle motif in 
the crystal structure of the C1 domain of Pasteurella multocida toxin (PMT). This structure 
motif is also found in the crystal structures of several clostridial glycosylating toxins (TcdA, 
TcdB, TcsL, and TcnA). The Ras/Rap1-specific endopeptidase (RRSP) module of the 
multifunctional autoprocessing repeats-in-toxins (MARTX) toxin produced by Vibrio vulnificus 
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has sequence homology to the C1-C2 domains of PMT, including a putative MLD. We have 
determined the solution structure for the MLDs in PMT and in RRSP using solution state NMR. 
We conclude that the MLDs in these two toxins assume a 4-helix-bundle structure in solution. 
 
2.3 Introduction 
Pathogenic bacteria produce a number of toxins that influence host-pathogen interactions 
to aid survival within a host.1 These toxins range in size from small molecules to large proteins 
and confer toxicity to hosts by targeting different cellular components and processes. Many 
bacterial toxins consist of an effector domain that requires a receptor-binding domain to reach 
specific cells and an additional translocation domain to facilitate delivery of the effector domain 
into the cytosol, where it gains access to its intracellular targets.  
The heterotrimeric G-protein-deamidating toxin from Pasteurella multocida (PMT) is a 
150-kDa protein comprised of N-terminal receptor-binding and translocation domains (residues 
1-568)2,3 and C-terminal activity domains (residues 569-1285). The crystal structure of the C-
terminal region is resolved into C1 (residues 569-719), C2 (residues 720-1104) and C3 (residues 
1105-1284) domains.4 The Gα-protein-deamidase activity of PMT was localized to the C3 
domain.5,6 The C1 domain contains a 4-helix-bundle motif (residues 589-668) that was shown to 
have membrane-targeting properties capable of bringing GFP to the plasma membrane.4,7 This 
structural motif was also observed in the clostridial glycosylating toxins (Fig. 2.1), including 
TcdA, TcdB, TcsL, and TcnA.8-11 
Similar sequences have been found in other bacterial toxins,12 a number of which have 
been shown to confer membrane localization of adjacent effector domains, and are referred to as 
membrane localization domains (MLDs).13 The MLD and its adjacent effector domain from a 
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MARTX toxin of Vibrio vulnificus (Ras and Rap1-specific endopeptidase RRSP; formerly 
DUF5) have the strongest homology to the C1-C2 domains of PMT.14,15 A crystal structure of the 
MLDRRSP alone (PDB 4ERR) is available, but this structure differs from the structure observed in 
the crystal structures with other domains present (PDB ID: 2EBF,4 3SS1,10 2BVL,9 2VL8,8 
2VK911). 
Considering the importance of this MLD motif in three classes of diverse toxins,13 a 
question arises regarding the solution structure of the MLDs. Thus, we determined the solution 
structures of MLDPMT and MLDRRSP using solution state NMR spectroscopy and compare the 
solution structures to the MLD moiety to that found in the crystal structures. 
 
2.4 Results 
2.4.1 Structure of MLDPMT 
MLDPMT contains 79 residues (Fig. 2.2a). In a previous study, predicted dihedral angles, 
determined by TALOS+, indicated that MLDPMT contains four helices.16 For this study, the 
improved TALOS-N program was used to predict dihedral angles and order parameters (Fig. 
2.2b).17 Similar to the TALOS+ results, the dihedral angle prediction indicates that MLDPMT 
forms 4 helices. Furthermore, the order parameter predictions indicate that the loop and termini 
residues experience greater mobility as compared to the helical residues.  
The overall fold of the solution structure is a 4-helix-bundle (Fig. 2.3a). Of the top 20 
structures (out of 200 total), the backbone RMSD of the ordered residues (corresponding to the 
helix residues) was determined to be 0.99 Å. Table 2.1 summarizes the statistics regarding the 
ensemble of structures. The ensemble of structures has an average of 2.6 ± 1.3 energy violations. 
 18 
Ramachandran analysis determined that 86.1 ± 2.8% of the residues were in favored regions, 
where violations were found in the mobile loop regions. 
As reported in Table 2.1, 1485 NOE restraints were used to calculate the structure. Of 
those NOE peaks, 109 were long-range peaks that helped to define the interhelical contacts. For 
example, contacts between E7 to L28 define the helix 1 and 2 interface, I34 to L46 for helix 2 
and 3, L47 to L77 for helix 3 and 4, and L9 to F70 for helix 1 and 4. These contacts are depicted 
on a representative structure (Fig. 2.4a), with the lowest RMSD with respect to the bundle of 20 
structures. 
2.4.2 Structure of MLDRRSP 
Similar to MLDPMT, MLDRRSP also forms 4 helices and contains mobile loop and termini 
residues as predicted by TALOS-N dihedral angles and order parameters (Fig. 2.2b). We have 
found that MLDRRSP also forms a 4-helix-bundle (Fig. 2.3b). The backbone RMSD (ordered 
residues) of the top 20 structures 0.96 Å. The structures have an average of 0.1 ± 0.3 violations, 
where 18 out of 20 structures have no violations. Ramachandran analysis determined that 96.8 ± 
2.0 % of the residues are within favored regions. Details regarding the statistics of the ensemble 
of structures can also be found in Table 2.1. 
For MLDRRSP, 1256 NOE peaks were used for the structure calculation where 114 long-
range peaks defined the interhelical contacts. The interhelical contacts were defined by the 
following NOE restraints: V7 to L29 for helix 1 and 2; V35 to A46 for helix 2 and 3; S47 to V77 
for helix 3 and 4; L10 to L73 for helix 1 to 4. The interhelical contacts are depicted on a 
representative structure (Fig. 2.4b). 
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2.4.3 Comparison of the solution structures of MLDPMT and MLDRRSP to the PMT crystal 
structure 
Two representative solution NMR structures, with the lowest RMSD with respect to the 
bundle of 20 structures (Fig. 2.5a and 2.5b), were superimposed (Fig. 2.5c). Comparison of these 
two MLDs revealed that the orientation of the helices is mostly preserved between the two 
structures with a backbone RMSD for the helix residues of 1.25 Å. 
 Helices 3 and 4 can be more closely aligned (Fig. 2.5d), where the backbone RMSD of 
helix 3 and 4 is 0.84 Å. The differences were primarily observed within the loops and end 
residues for helices 1 and 2. PMT contains a shorter helix 1 and a longer loop 1 as well as a 
shorter loop 2, which may account for the differences in the overall position of helix 1 and 2 in 
the bundle. 
 The C1 domain of PMT contains the 4-helix-bundle motif (Fig. 2.1b), as was previously 
determined by X-ray crystallography with a 1.9 Å resolution (PDB ID: 2EBF).4 Superposition of 
the representative solution structure of MLDPMT (Fig. 2.5a) with the crystal structure (Fig. 2.1b) 
showed that helices 3 and 4 are structurally similar (Fig. 2.6a), with a backbone RMSD of 0.75 
Å. Helix 1 is in a very different orientation while helix 2 has a slightly different orientation, 
which may be the result of decreased mobility in the crystal as compared to solution. 
Superposition of MLDRRSP (Fig. 2.5b) with the PMT crystal structure likewise showed 
that the structures are similar, with a backbone RMSD for helices 3 and 4 of 0.43 Å (Fig. 2.6b). 
The greatest difference in structure is found in helix 1, where the helix of RRSP is slightly longer 
than the helix of PMT. 
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2.5 Discussion 
Despite the great differences in the origins and functions of PMT and RRSP, both possess 
a structurally homologous MLD. Both MLDs are 4-helix-bundles in solution, confirming the 
previously predicted secondary structures based on TALOS+ chemical shift calculations.16,18 
These results agree with the corresponding MLDs found in the crystal structures of several 
clostridial toxins.8-11 Although there is precedent of the MLDRRSP alone forming a non-4-helix-
bundle dimeric structure (PDB ID: 4ERR), we confirm here that MLDRRSP is a 4-helix-bundle in 
solution at ambient temperature. 
The structures of MLDPMT and MLDRRSP are in overall agreement with each other. 
Differences are confined to the orientation of the mobile loops and ends, as well as slight 
differences in the lengths of the helices. In MLDRRSP, helix 3 is slightly longer and loop 2 is 
slightly shorter than that of MLDPMT. Furthermore, as indicated by the predicted order 
parameters (Fig. 2.3), loop 2 of MLDRRSP is more rigid than loop 2 of MLDPMT. MLDPMT in 
solution forms a 4-helix-bundle similar to that observed in the crystal structure of the C1 domain 
of full-length PMT (PDB 2EBF). The lengths and orientations of the helices 2, 3, and 4 are 
comparable between the structures. However, the orientation of helix 1 and loop 1 exhibit some 
differences, presumably due to the higher mobility of loop 1 in solution, which could impact the 
position of helix 1. As mentioned earlier, the loops are mobile and loop 1 in particular is more 
flexible because it is the longest unrestrained part of the sequence. Likewise, in comparing 
MLDRRSP (Fig. 2.4b) to the MLD motif in the PMT crystal structure, the structures are fairly 
similar, except with regard to the length of helix 1, where helix 1 of MLDRRSP in solution is 
longer than helix 1 in the crystal structure of MLDPMT. The similarity in structure of MLDRRSP to 
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MLDPMT reaffirms the homologous relationship between RRSP and PMT, and by analogy with 
MLDs of other clostridial glycosylating toxins.  
Formation of the 4-helix-bundle in solution in the absence of any other domains indicates 
that the 4-helix-bundle conformation is preferred and may be important for localization of the 
catalytic activity domain to the membrane target site. One possibility is that the 4-helix-bundle is 
required for localizing to the correct membrane associated target,15 presumably through 
recognition by an as-yet-unidentified receptor in the membrane. Alternatively, membrane 
localization may involve a conformational change of the MLD. In solution, the structures of 
MLDRRSP and MLDPMT correlate with all other MLD crystal structures previously determined for 
the full-length toxins. However, the crystal structure of MLDRRSP (PDB ID: 4ERR) is 
significantly different. In this crystal structure, the protein appears to form an antiparallel dimer, 
where the globular 4-helix-bundle opens up into a planar structure and the nonpolar faces of 
helices 1 and 4 of one molecule are interacting with the nonpolar faces of helices 2 and 3 of the 
other molecule.  
This crystal structure may indicate a dimerization process that occurs when binding to the 
membrane, so that the 4-helix-bundle opens into a planar structure exposing the nonpolar faces 
of the protein and facilitating the nonpolar faces of the protein to embed into the hydrophobic 
section of the membrane. However, this may also be an artifactual crystal structure of a domain 
swapped19 structure of MLDRRSP. Without further structural data of the membrane-bound form of 
MLD, we are unable to confirm the extended conformation of this putative intermediate, 
unfolded structure of the MLD. Having now solved the structure of the MLD in solution, we are 
in a position to study the structure of the membrane-bound form and determine whether MLDs 
undergo large conformational changes upon localizing to and interacting with target membranes. 
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2.6 Materials and Methods 
2.6.1 Expression and purification of MLDPMT and MLDRRSP 
 Uniformly 13C,15N-labeled recombinant MLDPMT and MLDRRSP proteins were expressed 
and purified from E. coli BL21(DE3) cells (Promega, Fitchburg, WI) grown in medium 
containing 13C,15N-BioExpress (Cambridge Isotopes Laboratories, Inc., Andover, MA), U-15N 
NH4Cl, and U-13C glucose, as previously described.16,18 
NMR spectroscopy 
 Solution NMR spectra were collected on a Varian INOVA (600 MHz 1H) spectrometer 
with a 5-mm triple resonance (1H–13C–15N) triaxial gradient probe using VnmrJ 2.3 with the 
BioPack suite (School of Chemical Sciences NMR Facility at the University of Illinois at 
Urbana-Champaign). 
 Spectra of solution state MLDPMT were collected at 30 ºC with a 1 mM protein sample in 
20 mM bis-Tris buffer, pH 6.0, containing 100 mM NaCl, 10% D2O (v/v) and 0.01% 4,4- 
dimethyl-4-silapentane-1-sulfonic acid (DSS), as previously described,16 or on a 99% D2O back-
exchanged sample (1 mM in 20 mM bis-Tris buffer, pH 6.0, containing 100 mM NaCl, 99% 
D2O, and 0.01% DSS). For MLDRRSP, data was also collected at 30 ºC with a 1 mM sample in 20 
mM Tris buffer, pH 7.4, containing 500 mM NaCl, 10% D2O, 0.01% DSS, and 2 mM EDTA, as 
described previously,18 or on a 99% D2O back-exchanged sample (1 mM sample in 20 mM Tris, 
pH 7.4, containing 500 mM NaCl, 99% D2O, 0.01% DSS, and 2 mM EDTA). Distance 
measurements for both proteins were made using 13C-HSQC-NOESY spectra with a mixing time 
of 150 ms and 15N-HSQC-NOESY spectra with a mixing time of 150 ms. Spectra were 
processed with NMRPipe20 and analyzed in Sparky.21  
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2.6.2 Distance restraints and structure calculation 
 A total of 200 structures were calculated in XPLOR-NIH using the NOE distance 
restraints and dihedral angles (Table 2.1),22,23 and the top 20 structures are presented here. The 
structures of MLDPMT were calculated with 1,485 NOE restraints and 75 dihedral angles (Fig. 
2.3a), while those of MLDRRSP were calculated with 1,256 NOE restraints and 73 dihedral angles 
(Fig. 2.3b). NOE distance restraints were determined using the PASD algorithm.24,25 NOESY 
peaks (data height and peak position) from carbon and nitrogen edited 3D NOESY experiments 
were imported into the PASD algorithm, where the peaks were categorized into standard distance 
bins: strong (80%+ intensity): 1.8 Å to 2.7 Å; medium (50% to 80% intensity): 1.8 Å to 3.3 Å; 
weak (20% to 50% intensity): 1.8 Å to 5.0 Å; very weak (0% to 20 % intensity): 1.8 Å to 6.0 Å. 
Furthermore, the algorithm increases the upper bound of the methyl peak distance ranges by 0.5 
Å to compensate for the larger intensities of methyl peaks. Dihedral angles and order parameters 
were determined using TALOS-N.17 The chemical shifts used for these calculations were 
previously published.16,18  
RMSD calculations were made using VMD software for both backbone and heavy atoms 
for the top 20 structures.26 For comparison of any pair of structures, the RMSD calculations were 
based on global alignments for the region of interest. Ramachandran analysis was calculated 
using Molprobity software through the PSVS server to verify angular geometry.27,28  
2.6.3 Data deposition 
The ensemble of structures of both proteins was deposited into the Protein Data Bank. 
The PDB ID for MLDPMT is 2N9V and the PDB ID for MLDRRSP is 2N9W. 
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2.7 Figures and Table 
 
Fig. 2.1. Comparison of sequences and crystal structures of putative MLDs in bacterial toxins. (a) Amino acid 
sequence alignment with conserved residues color-coded (purple: hydrophobic, brown: basic, green: acidic, orange: 
polar) and (b) the corresponding crystal structures of the individual and aligned 4-helix-bundle motifs found in PMT 
(PDB ID: 2EBF), TcdA (PDB ID: 3SS1), TcdB (PDB ID: 2BVL), TcsL (PDB ID: 2VL8), and TcnA (PDB ID: 
2VK9). 
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Fig. 2.2. Comparison of sequences and crystal structures of putative MLDs in bacterial toxins. (a) Amino acid 
sequence alignment with conserved residues color-coded (purple: hydrophobic, brown: basic, green: acidic, orange: 
polar) and (b) the corresponding crystal structures of the individual and aligned 4-helix-bundle motifs found in PMT 
(PDB ID: 2EBF), TcdA (PDB ID: 3SS1), TcdB (PDB ID: 2BVL), TcsL (PDB ID: 2VL8), and TcnA (PDB ID: 
2VK9). 
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Fig. 2.3. Secondary structures and dynamics determined by TALOS-N. (a) Amino acid sequence alignment of 
MLDPMT and MLDRRSP. Non-native termini residues are in grey, loop residues are in blue, and helix residues are in 
red. Dihedral angles (φ, ψ) and order parameters of MLDPMT (b) and MLDRRSP (c), predicted from TALOS-N are 
plotted. 
 
 
 
 
Fig. 2.4. Interhelical NOEs of MLDPMT and MLDRRSP. Interhelical NOE contacts are mapped onto the structures of 
MLDPMT (a) and MLDRRSP (b). Contacts in MLDPMT include E7 to L28 (H1-H2), I27 to Y57 (H2-H3), I34 to L46 
(H2-H3), M47 to L77 (H3-H4), I54 to R74 (H3-H4), and L9 to F70 (H1-H4). Contacts in MLDRRSP include V7 to 
L29 (H1-H2), I28 to Y57 (H2-H3), V35 to A46 (H2-H3), I58 to N67 (H3-H4), S47 to V77 (H3-H4), and L10 to L73 
(H1-H4). 
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Fig. 2.5. Comparison of the two solution structures of the MLDPMT and MLDRRSP with each other. Shown are 
representative solution structures of (a) MLDPMT alone in red, (b) MLDRRSP alone in cyan, (c) superimposed with 
each other with all 4 helices aligned, and (d) superimposed with each other with helix 3 and 4 aligned. 
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Fig. 2.6. Comparison of the representative solution structures of MLDPMT and MLDRRSP with the corresponding 
region in the crystal structure C1 domain of PMT. Shown are (a) the superposition of solution MLDPMT (red) and the 
crystal structure (blue) and (b) the superposition of solution MLDRRSP (cyan) and the crystal structure. Helices 3 and 
4 were aligned in each superposition. 
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Table 2.1: Restraints and Statistics of Top 20 structures 
NMR Distance Restraints MLDPMT MLDRRSP 
Total NOE 1485 1256 
Intra-residue NOE 606 492 
Inter-residue NOE 503 445 
Sequential (|i - j| = 1) 238 180 
Medium-range (|i - j| < 4) 156 151 
Long-range (|i - j| ≥ 5) 109 114 
Ambiguous NOE 376 319 
Dihedral Angle Restraints     
φ (TALOS-N) 75 73 
ψ (TALOS-N) 75 73 
      
Violations     
Total Violations 2.6 ± 1.3 0.1 ± 0.3 
NOE Violations 0 0 
CDIH Violations 2.3 ± 1.2 0 
van der Waals Violations 0.3 ± 0.6 0.1 ± 0.3 
Deviations from Idealized Geometry     
Bond Lengths (Å) 0.003 ± 0.000 0.002 ± 0.000 
Bond Angles (º) 0.449 ± 0.010 0.380 ± 0.006 
Impropers (º) 0.337 ± 0.013 0.246 ± 0.015 
Ramachandran plot statistics (Molprobity)      
Favored Region (%) 89.6 98.7 
Allowed Region (%) 8.1 1.2 
Disallowed Region (%) 2.2 0.1 
RMSD (Ordered Residues)     
Backbone RMSD (Å) 0.97 0.97 
Heavy Atom RMSD (Å) 1.76 1.73 
 
 
 
 
 
 
 
 30 
2.8 References 
1. Lemichez E, Barbieri JT (2013) General aspects and recent advances on bacterial protein 
toxins. Cold Spring Harb Perspect Med 3, a013573. 
2. Pullinger GD, Sowdhamini R, Lax AJ (2001) Localization of functional domains of the 
mitogenic toxin of Pasteurella multocida. Infect Immun 69, 7839-7850. 
3. Brothers MC, Ho M, Maharjan R, Clemons NC, Bannai Y, Waites MA, Faulkner MJ, 
Kuhlenschmidt TB, Kuhlenschmidt MS, Blanke SR, Rienstra CM, Wilson BA (2011) 
Membrane interaction of Pasteurella multocida toxin involves sphingomyelin. FEBS J 
278, 4633-4648. 
4. Kitadokoro K, Kamitani S, Miyazawa M, Hanajima-Ozawa M, Fukui A, Miyake M, 
Horiguchi Y (2007) Crystal structures reveal a thiol protease-like catalytic triad in the C-
terminal region of Pasteurella multocida toxin. Proc Natl Acad Sci USA 104, 5139-5144. 
5. Aminova LR, Luo SH, Bannai Y, Ho M, Wilson BA (2008) The C3 domain of 
Pasteurella multocida toxin is the minimal domain responsible for activation of G(q)-
dependent calcium and mitogenic signaling. Prot Sci 17, 945-949. 
6. Orth JHC, Preuss I, Fester I, Schlosser A, Wilson BA, Aktories K (2009) Pasteurella 
multocida toxin activation of heterotrimeric G proteins by deamidation. Proc Natl Acad 
Sci USA 106, 7179-7184. 
7. Kamitani S, Kitadokoro K, Miyazawa M, Toshima H, Fukui A, Abe H, Miyake M, 
Horiguchi Y (2010) Characterization of the membrane-targeting C1 domain in 
Pasteurella multocida toxin. J Biol Chem 285, 25467-25475. 
8. Jank T, Ziegler MOP, Schulz GE, Aktories K (2008) Inhibition of the glucosyltransferase 
activity of clostridial Rho/Ras-glucosylating toxins by castanospermine. FEBS Lett 582, 
2277-2282. 
9. Reinert DJ, Jank T, Aktories K, Schulz GE (2005) Structural basis for the function of 
Clostridium difficile toxin B. J Mol Biol 351, 973-981. 
10. Pruitt RN, Chumbler NM, Rutherford SA, Farrow MA, Friedman DB, Spiller B, Lacy 
DB (2012) Structural determinants of Clostridium difficile toxin A glucosyltransferase 
activity. J Biol Chem 287, 8013-8020. 
11. Ziegler MOP, Jank T, Aktories K, Schulz GE (2008) Conformational Changes and 
Reaction of Clostridial Glycosylating Toxins. J Mol Biol 377, 1346-1356. 
 31 
12. Geissler B, Tungekar R, Satchell KJF (2010) Identification of a conserved membrane 
localization domain within numerous large bacterial protein toxins. Proc Natl Acad Sci 
USA 107, 5581-5586. 
13. Geissler B, Ahrens S, Satchell KJF (2012) Plasma membrane association of three classes 
of bacterial toxins is mediated by a basic-hydrophobic motif. Cell Microbiol 14, 286-298. 
14. Antic I, Biancucci M, Satchell KJF (2014) Cytotoxicity of the Vibrio vulnificus MARTX 
toxin Effector DUF5 is linked to the C2A Subdomain. Proteins: Struct, Funct, Bioinf 82, 
2643-2656. 
15. Antic I, Biancucci M, Zhu YM, Gius DR, Satchell KJF (2015) Site-specific processing of 
Ras and Rap1 Switch I by a MARTX toxin effector domain. Nat Commun 6, 7396. 
16. Brothers MC, Geissler B, Hisao GS, Satchell KJF, Wilson BA, Rienstra CM (2014) 
Backbone and side-chain resonance assignments of the membrane localization domain 
from Pasteurella multocida toxin. Biomol NMR Assign 8, 221-224. 
17. Shen Y, Bax A (2013) Protein backbone and sidechain torsion angles predicted from 
NMR chemical shifts using artificial neural networks. J Biomol NMR 56, 227-241. 
18. Brothers MC, Geissler B, Hisao GS, Wilson BA, Satchell KJF, Rienstra CM (2014) 
Backbone and side-chain assignments of an effector membrane localization domain from 
Vibrio vulnificus MARTX toxin. Biomol NMR Assign 8, 225-228. 
19. Liu Y, Eisenberg D (2002) 3D domain swapping: As domains continue to swap. Prot Sci 
11, 1285-1299. 
20. Delaglio F, Grzesiek S, Vuister GW, Zhu G, Pfeifer J, Bax A (1995) NMRPipe: A 
multidimensional spectral processing system based on UNIX pipes. J Biomol NMR 6, 
277-293. 
21. Goddard TD, Kneller DG (2008) SPARKY 3. University of California, San Francisco  
22. Schwieters CD, Kuszewski JJ, Tjandra N, Clore GM (2003) The Xplor-NIH NMR 
molecular structure determination package. J Magn Reson 160, 65-73. 
23. Schwieters CD, Kuszewski JJ, Clore GM (2006) Using Xplor-NIH for NMR molecular 
structure determination. Prog Nucl Mag Res Sp 48, 47-62. 
24. Kuszewski J, Schwieters CD, Garrett DS, Byrd RA, Tjandra N, Clore GM (2004) 
Completely automated, highly error-tolerant macromolecular structure determination 
 32 
from multidimensional nuclear overhauser enhancement spectra and chemical shift 
assignments. J Am Chem Soc 126, 6258-6273. 
25. Kuszewski JJ, Thottungal RA, Clore GM, Schwieters CD (2008) Automated error-
tolerant macromolecular structure determination from multidimensional nuclear 
Overhauser enhancement spectra and chemical shift assignments: improved robustness 
and performance of the PASD algorithm. J Biomol NMR 41, 221-239. 
26. Humphrey W, Dalke A, Schulten K (1996) VMD: Visual molecular dynamics. J Mol 
Graph Model 14, 33-38. 
27. Lovell SC, Davis IW, Adrendall WB, de Bakker PIW, Word JM, Prisant MG, Richardson 
JS, Richardson DC (2003) Structure validation by C alpha geometry: phi,psi and C beta 
deviation. Proteins: Struct, Funct, Genet 50, 437-450. 
28. Bhattacharya A, Tejero R, Montelione GT (2007) Evaluating protein structures 
determined by structural genomics consortia. Proteins: Struct, Funct, Bioinf 66, 778-795. 
 
 
 33 
CHAPTER 3 
Optimization of expression and purification of 13C-labeled amphotericin B 
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3.2 Abstract 
 Amphotericin B is a natural product expressed by Streptomyces nodosus. The molecule 
can be isotopically labeled for NMR spectroscopy through biosynthesis. In this process, the 
bacterium is grown on isotopically labeled media and the bacterium will express the labeled 
analyte. However, the process of expressing AmB is time consuming and costly. An optimized 
method of expression and purification has been developed to yield labeled AmB more feasibly. 
 
3.3 Introduction 
 Isotopic labeling of analytes is a critical component of NMR studies.1 In the study of 
amphotericin B (AmB), the efficient production of isotopically 13C-labeled compound has 
provided a significant challenge. AmB is a natural product expressed by Streptomyces nodosus 
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and isotopically 13C labeled AmB is produced when S. nodosus is cultured on an isotopically 
enriched medium.2-5 By doing so, the bacterium will use isotopically labeled components to 
express isotopically labeled AmB. 
Preparation of isotopically 13C-labeled AmB according to the previously available 
protocols2-5 required a significant amount of time: two weeks for expression and an additional 
two weeks for purification. Furthermore, the purification methods employed previously2,3 often 
suffered from irreproducibility and low yield (10 to 15 mg purified material from 240 mL of 
culture). 
Reported here are extensive improvements that have been made in the procedure of 
expression, extraction, and purification, as depicted in Fig. 3.1, which has resulted in a 
reproducible method for sample preparation. The improvements include the preparation and 
maintenance of S. nodosus glycerol stocks, an improved protocol for extraction of AmB from 
cultures using dimethyl sulfoxide (DMSO), and the implementation of medium pressure liquid 
chromatography (MPLC) in the purification process. 
 
3.4 Materials and Methods 
3.4.1 AmB expression from Streptomyces nodosus 
 The procedure for AmB expression was extensively modified from McNamara, et al.4 
and Anderson, et al.2 Spores of S. nodosus were purchased from American Type Culture 
Collection (Manassas, VA, cell line 14899). Spores were rehydrated with 1 mL of a liquid 
medium (1 g/L yeast extract, 1 g/L beef extract. 1 g/L tryptose, pH 7.0), which was used to 
streak agar slants (1 g/L yeast extract, 1 g/L beef extract. 1 g/L tryptose, 15 g/L agar, 1 mg/L 
FeSO4•7H2O, pH 7.0). The slants were incubated at 30 ºC for one week. 
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After the slants matured, the colonies were then resuspended in 0.02% Polyoxyethylene 
(20) sorbitan monooleate and were used to inoculate three 500-mL culture flasks (500 µL of 
resuspended culture per flask) each containing 100 mL pregrowth media (10 g/L glucose, 10 g/L 
yeast extract, pH 7.0). The pregrowth culture was shaken at 200 rpm, 28 ºC for 3 days. 
 For the expression, 12 250-mL culture flasks containing 20 mL of growth medium each 
(60 g/L Dextrin from corn Type II, 30 g/L Soybean flour Type I, 10 g/L calcium carbonate, pH 
7.0; 240 mL total) were autoclaved for 15 minutes at 121 ºC and subsequently cooled. A 50% 
w/v solution of isotopically labeled glucose (typically U-13C) in water was made, sterile filtered, 
and aliquoted into the 12 flasks for a final concentration of 20 g/L. The growth flasks were then 
inoculated with the healthiest pregrowth culture (1 mL pregrowth culture per flask). The 
inoculated flasks were then placed in a shaker (28 ºC, 200 rpm) for 7 days. During the growth 
process, the cultures were pulse fed with labeled glucose (140 µL of 50 % w/v labeled glucose 
per flask) at 24, 40, 44, 48, 64, 68, 72, 88, and 92 hours post inoculation. 
3.4.2 Glycerol stocks 
 Glycerol stocks were made using the pregrowth culture as previously described by 
McNamara, et al.4 Briefly, 500 µL of culture was mixed with 500 µL of a cryopreservative 
solution (20 mg/mL glycerol, 10 mg/mL α-lactose; sterile filtered) and stored at -80 ºC. When 
expressing AmB with glycerol stocks, agar slants were streaked with glycerol stocks instead of 
rehydrated spores and every subsequent step was followed as described above. 
3.4.3 Culture harvest and AmB extraction 
 Cultures were pooled and centrifuged (8,000 x g, 4 ºC, 15 min.) in 50 mL NalgeneTM Oak 
Ridge High-Speed centrifuge tubes (Nalge Nunc; Rochester, NY). The supernatant was collected 
in a round bottom flask and was rotary evaporated until it was a dried solid. The material was 
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stored at -80 ºC until further AmB extraction. Cell pellets were lyophilized and stored at -80 ºC 
until extraction and purification. 
AmB was extracted from the dried media by resuspending the material in methanol 
(MeOH) or DMSO and pelleting out the solid material (8,000 x g, 4 ºC for 15 min). The 
supernatant was collected and the extraction process was repeated until there were no detectable 
amounts of AmB present in MeOH (determined using analytical HPLC). The typical number of 
extractions is three or four. The MeOH solutions were pooled and rotary evaporated. The crude 
AmB was then stored at -80 ºC until purification. 
AmB was extracted from lyophilized cell pellets by first homogenizing the pellets in 
DMSO (approximately 30 mL per extraction) and then centrifuging (8,000 x g, 4 ºC for 15 min). 
The supernatant was collected and the DMSO homogenization process was repeated multiple 
times, until there was no more AmB in the resulting supernatant (determined using analytical 
HPLC). The crude AmB solutions were then pooled and DMSO was removed by lyophilization. 
The resulting crude AmB was stored at -80 ºC until purification. 
3.4.4 AmB purification 
Crude extracted AmB was subjected first to purification using MPLC to remove most 
impurities, such as media components and metabolites that were co-extracted, and was further 
purified using high performance liquid chromatography (HPLC). MPLC purification was 
performed using a CombiFlash® Rf system (Teledyne Isco, Lincoln, NE) using reverse phase C-
18 silica gel as the column resin. Crude AmB was loaded onto the column as a solid sample, 
where material was adsorbed onto Celite 545. Adsorption was achieved by first resuspending the 
crude material in a minimal amount of N,N-Dimethylformamide. Celite 545 was added and the 
mixture was homogenized with MeOH and rotary evaporated. The process was repeated several 
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times until the sample appeared to be a homogeneous powder. The sample was then placed under 
high vacuum for at least 14 hrs before being packed into a sample cartridge. 
One of two solvent systems was used: 5 mM ammonium acetate as solvent A and 
acetonitrile (MeCN) as solvent B or 5 mM ammonium acetate as solvent A and MeOH as solvent 
B (solvent selection discussed in section 3.5.4). The MPLC column was equilibrated with in 95% 
solvent B and 5% solvent A. Sample was loaded and eluted by running the following gradient: 
95% solvent A for 5 min.; ramp from 5% to 100% solvent B over 10 min., 100% solvent B for 
10 min at a flow rate of 30 mL/min. Fractions that had a yellow hue were collected and the 
solvent was removed using rotary evaporation. Residual ammonium acetate was removed from 
the sample by resuspending and bath sonicating the solid sample in water and rotary evaporating 
the sample, azeotroping with excess toluene. This process was repeated at least three times 
before placing the samples under high vacuum for at least 14 hrs. HPLC purification was then 
performed as previously described.2 
3.4.5 Quantification of AmB using analytical HPLC 
 Quantification of AmB was performed using analytical HPLC. Using purified AmB, a 
series of standards (determined using UV-Vis) were made at 5 µM, 10 µM, 20 µM, 30 µM, 40 
µM, 50 µM, using DMSO for dilutions. After estimating the concentration of AmB in samples of 
interest (determined using UV-Vis), a dilution series was made and samples were filtered 
through a 0.2 µm syringe filter. Samples were run tandem on an Agilent 1200 Infinity series 
HPLC (Agilent Technologies, Santa Clara, CA) equipped with a SunFire C18 5 µm column 
(Waters Corporation, Milford, MA) at a flow rate of 1.2 mL/min. Gradient elution was achieved 
with a gradient from 95:5 of 5 mM ammonium acetate:MeCN to 5:95 of 5 mM ammonium 
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acetate:MeCN over 8 min. A calibration curve was generated from the measurement of standard 
samples and used to determine the concentration of AmB in unknown samples. 
3.4.6 Mass spectrometry analysis 
 Mass spectrometry (MS) data for AmB samples were collected by the Mass Spectrometry 
Laboratory at the School of Chemical Sciences (University of Illinois at Urbana-Champaign). A 
small portion of the solid material was dissolved in DMSO and electrospray ionization was used 
to ionize the material. A time-of-flight mass analyzer was used to determine the mass to the 
charge ratio of each component. 
 
3.5 Results and Discussion 
3.5.1 Improvements in expression using glycerol stocks 
 Relative to the previously reported procedure by McNamara, et al,4 one major 
modification is in the expression of AmB from glycerol stocks of S. nodosus. Previously, 
glycerol stocks were used to directly inoculate the pregrowth liquid cultures. This procedure 
suffered from irreproducibility, leading us to only express AmB from S. nodosus spores. 
However, the cost associated with purchasing spores ($300 per growth) had made the procedure 
unsustainable, requiring further investigation of expressions starting from glycerol stocks. 
 Glycerol stocks of S. nodosus were first prepared in a similar manner as was previously 
done.4 However, rather than inoculating the pregrowth liquid media with the stock, agar slants 
were streaked with the glycerol stock similar to the process of growing cultures from spores. 
Once the cultures matured, the remaining procedure for AmB expression was performed. Since 
implementing this extra step into the protocol, the expression has become reproducible and the 
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process no longer requires the purchase of spores, decreasing the cost of isotopically labeled 
AmB expression. 
3.5.2 Extraction of AmB from cell pellets 
 When AmB is expressed by S. nodosus, the molecule is excreted out into the media. The 
extraction of AmB from cultures and the purification of AmB has been done in multiple ways.6 
One method that has been previously applied2,3 utilizes the detergent Aliquat 336. In this 
extraction, the detergent solubilizes AmB into ethyl acetate directly from the culture (cell and 
media). Unfortunately, the extraction process typically was irreproducible and the detergent was 
not easily removed from the AmB. This process often required multiple column chromatography 
steps and led to a low yield of purified AmB, with empirical yields resulting around 10-15 mg. 
 Given the challenges of using Aliquat 336, we developed a new method of extraction that 
does not require the use of any detergent. Instead, DMSO, a solvent in which AmB is highly 
soluble, was used for solubilizing AmB. Cells are first separated from the media through 
centrifugation. The resulting supernatant is removed and set aside for further purification 
(discussed in section 3.5.3). The cell pellets were then flash frozen and lyophilized to remove 
any excess water. The dried cells were homogenized in DMSO to dissolve AmB. DMSO is 
effective in solubilizing the AmB without solubilizing a large portion of the cellular debris and 
the insoluble portions of the material are pelleted out using centrifugation. The AmB containing 
supernatant is then collected. 
The process of homogenization and centrifugation is repeated multiple times to remove 
the maximum amount of AmB. This was first observed when empirically testing the extraction. 
First, the cell pellets were homogenized in a total of approximately 30 mL of DMSO and the 
cellular debris was pelleted. The resulting supernatant was then subject to the proceeding 
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purification steps. Analytical HPLC measurements were performed on a small aliquot of the 
supernatant material (Fig. 3.2a), which indicated a large portion of AmB, which has a retention 
time near 6 minutes, along with other crude impurities. The pellets were then washed a second 
time, again with approximately 30 mL of DMSO. Performing analytical HPLC analysis of the 
material from the second wash (Fig. 3.2b) also shows AmB present in the second wash along 
with other contaminants. Therefore, it was necessary to perform DMSO extraction at least three 
times to sufficiently extract AmB from the pellets. 
3.5.3 Extraction of AmB from media 
 In extracting AmB from the media, the spent media is pooled into a large round bottom 
flask and the liquid is removed using rotary evaporation under high vacuum. This results in a 
tacky film containing AmB along with other media components. AmB can be extracted from the 
film using DMSO similar to the extraction method used with the cell pellets. However, DMSO 
also solubilizes many of the other media components. To minimize the amount of impurities in 
the extracted sample, AmB was extracted from the material using MeOH. Though MeOH does 
not solubilize AmB as well as DMSO, MeOH is capable of solubilizing AmB while keeping 
many of the other media components insoluble, allowing for a cleaner extraction. 
 The insoluble material is pelleted out using centrifugation and the AmB-MeOH solution 
is pooled into a round bottom flask. MeOH is removed with rotary evaporation and the crude 
AmB is then ready for purification. 
3.5.4 Development of the MPLC protocol 
 To ensure high purity for SSNMR studies, high performance liquid chromatography 
(HPLC) must be used.2 However, before AmB can be purified using HPLC, a crude purification 
step is necessary to remove the bulk of the impurities that was co-extracted with AmB from the 
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cultures. In the old purification method, crude purification was done using standard column 
chromatography.2 This method required the use of C-18 reverse phase silica gel and was a 
gradient elution using 5 mM ammonium acetate and acetonitrile (MeCN) as the mobile phase. 
However, given the time consuming nature of manual column chromatography as well as the 
large amount of solvent and resin required, a new crude purification method using medium 
pressure liquid chromatography (MPLC)7 method was developed. The automated and 
pressurized method of MPLC allows for the use of a smaller column, which leads to less resin 
and solvent being consumed per purification. 
 In developing the new procedure, conditions such as flow rate, gradient ramp rate, and 
solvent system were tested. In optimizing the protocol, the solvent system used in the old manual 
purification procedure was first used (5 mM ammonium acetate + MeCN gradient). From 
previous experience, it was expected that the majority of AmB would be eluted at a gradient of 
55% 5 mM ammonium acetate and 45% MeCN. 
In this first test of the gradient, approximately 51 mg of commercially available NA AmB 
was adsorbed onto Celite 545. Using a flow rate of 30 mL/min, the following gradient was used: 
5% MeCN for 5 min, ramp from 5% MeCN to 100% MeCN over 10 min, 100% MeCN for 10 
min (Fig. 3.3a). Fractions were collected for the entire run of this gradient and contents of each 
fraction was analyzed using analytical HPLC measurements. A small aliquot from each fraction 
was diluted in DMSO for these measurements and it was determined that fractions 13 (~ 50% 
MeCN) to 25 (100% MeCN) contained AmB. These fractions were then pooled and a 
quantitative HPLC measurement was performed (Fig. 3.3a). This analysis showed that 
approximately 18 mg of AmB was eluted in a single application of this gradient. This low 
recovery of AmB from this process indicated a problem with the gradient. Furthermore, after the 
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gradient had run, a bright yellow color was observed on the column resin indicating that AmB 
may have been stuck on the column. To verify, the same gradient was applied a second time on 
the exact same column (Fig. 3.3b). Similar HPLC measurements were performed on each 
fraction, which indicated that an additional 6 mg of AmB was eluted in the second run. 
Therefore, it was concluded that the applied gradient was not optimal because AmB was not 
being completely eluted from the column.  
 One of the possible reasons why the elution of AmB was limited by the gradient was the 
low solubility of AmB in MeCN. To determine whether solubility may be a factor, another 
solvent system was tested. MeOH was selected as alternate solvent for MeCN since MeOH has 
commonly been used in reverse phase chromatography and is able to solubilize AmB better than 
MeCN. Using 45 mg of commercially available AmB, the following gradient was tested: at 30 
mL/min, 5% MeOH for 5 min, ramp from 5% MeOH to 100% MeOH over 10 min, 100% MeOH 
for 10 min (Fig. 3.4a). Similar to the MeCN test runs, HPLC measurements were conducted on 
an aliquot of each fraction. By using MeOH, AmB was eluted in all fractions above 80% MeOH. 
Fractions 18 to 24 and fractions 25 to 32 were pooled separately and the amount of AmB was 
determined using quantitative HPLC (Fig. 3.4b,c). Fractions 18 to 24 contained approximately 
32 mg of AmB and the latter fractions contained approximately 1.7 mg. The higher recovery of 
material and the lack of a yellow color on the column indicated that MeOH is a better solvent 
system for the MPLC purification. 
 Using this optimized MPLC procedure, the purification of the crude AmB extracted from 
culture was tested (Fig. 3.5a). Thirty fractions were collected and pooled into four separate 
flasks. Analytical HPLC and MS measurements were then conducted with the pooled samples. 
Flask 1 contained fractions 1 to 9, which pool the elutions from 5% MeOH to 20% MeOH. The 
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HPLC and MS data (Fig. 3.5b) indicate that there was some AmB being eluted below 20% 
MeOH. However, the mass spectrum indicated that the sample contained a number of many low 
molecular weight impurities. Because of the high level of impurities in these fractions, it was 
decided that any material eluted below 20% MeOH would be discarded.  
The second flask contained fractions 10 to 16, which are fractions containing elutions 
between 20% and 80% MeOH along the gradient. The HPLC and MS data (Fig. 3.5c) show no 
detectable levels of AmB. Flask 3 contains fractions 17 to 24, which correspond to elutions with 
80% MeOH to 100% MeOH and flask 4 contains the remaining fractions (100% MeOH). Both 
HPLC and MS of flask 3 (Fig. 3.5d) and flask 4 (Fig. 3.5e) show that AmB elutes when the 
percentage of MeOH is greater than 80%. In addition, it was observed that AmB co-elutes with 
other components. Components that co-eluted with AmB are a result of insufficient resolution of 
the MPLC step. Therefore, preparative scale HPLC purification is necessary. Material that is 
collected from the MPLC purification can then be purified using HPLC, as had been done 
previously.2 It is important to note that unlike the previous extraction methods that utilized 
Aliquat 336, the DMSO extraction couple with the MPLC purification procedure requires only a 
single crude purification step prior to HPLC purification. Thus, the purification process is now 
more efficient. 
 
3.6 Conclusion 
The production yield for isotopically 13C labeled AmB was improved by optimizing the 
procedure of expressing and purifying AmB from natural product biosynthesis. The 
optimizations included improving the expression from glycerol stocks of S. nodosus, extraction 
of AmB using DMSO, and the implementation of MPLC. The new procedure has reduced the 
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likelihood of failures in the expression process and has improved the efficiency of the 
purification. 
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3.7 Figures 
 
Fig. 3.1. The expression and purification of AmB from Streptomyces nodosus is summarized into four steps: (a) 
growth, (b) extraction from pellets, (c) extraction from media, (d) purification. 
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Fig. 3.2. Analytical HPLC chromatograms of crude extracts from cell pellets. Material from the first extraction (a) 
and second (b) contains AmB, indicating multiple rounds of extraction are necessary to remove the bulk of AmB. 
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Fig. 3.3. MPLC traces and corresponding analytical HPLC traces of the MPLC program test using 5 mM 
ammonium acetate as solvent A and MeCN as solvent B. A sample was loaded and the program ran  (a) and the 
program as repeated a second time on the same sample (b). Fractions were pooled from the MPLC runs and 
analytical HPLC measurements were conducted to quantify the amount of AmB. This test indicated that the program 
or solvent system insufficiently eluted AmB from the MPLC column. 
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Fig. 3.4. (a) MPLC trace for a MPLC program test using 5 mM ammonium acetate as solvent A and MeOH as 
solvent B. Fractions 18 to 24 were pooled and fractions 25 to 32 were pooled for quantitative HPLC measurements 
(b and c respectively). 
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Fig. 3.5. (a) Trace of the MPLC purification performed on crude AmB extracted from cell pellets. Fractions 1 to 9, 
fractions 10 to 16, fractions 17 to 24, and fractions 25 to 30 were pooled into separate flasks and the material in each 
flask was analyzed using analytical HPLC and MS (b-e respectively). This analysis showed that AmB elutes from 
the column when the gradient is above 80% MeOH. 
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CHAPTER 4 
Solid-state NMR study of amphotericin B aggregates 
 
4.1 Notes and Acknowledgements 
This work was supported by grants from the National Institutes of Health (R01-
GM112845), the University of Illinois Centennial Scholars Award (to C.M.R.), and the J & M 
Witt Fellowship (to G.S.H.). The author wishes to thank Ms. Samantha Phinney for expressing 
and purifying the amphotericin B used in this study (both labeled and natural abundance) and Dr. 
Danielle Gray for collecting the powder diffraction data. The author also wishes to thank Prof. 
Chad Rienstra, Prof. Marty Burke, and Ms. Anna SantaMaria for important discussion and 
research guidance. 
 
4.2 Abstract 
 The lifesaving antifungal drug amphotericin B forms aggregates. Depending upon the 
sample preparation, the aggregates can be heterogeneous. Critical factors that influence the 
aggregation states include hydration and sample heating. Reported here is a characterization of 
some of the different aggregates of AmB using solid-state NMR spectroscopy. Qualitative 
comparisons between spectra were performed as well as chemical shift assignments of AmB 
samples prepared in different methods. 
 
4.3 Introduction 
 Amphotericin B (AmB; Fig. 4.1) has long been known as the gold standard of antifungal 
drug to treat life threatening fungal infections.1,2 This is primarily due to its unique characteristic 
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of having no clinically relevant antimicrobial resistance.3 However, the high toxicity of the 
molecule prevents it from being used frequently as a therapeutic and can only be used as a last 
resort.4 
AmB has a tendency to form aggregates,5-10 which have been hypothesized to effect 
toxicity.5,9,11,12 In addition to forming aggregates, AmB also has an inability to crystallize unless 
derivatized.13,14 Furthermore, it is highly insoluble in many solvents and has been shown to 
forms large nanotapes.15 A solid-state NMR spectroscopy (SSNMR) study of AmB also revealed 
that AmB may have multiple states in a single sample preparation, highlighting the 
heterogeneous nature of the molecule.16  
AmB, much like other molecules,17,18,19,20 changes conformation or is heterogeneous 
depending upon the sample preparation. One of the critical factors observed in the previous work 
has been the hydration of the sample. In addition to hydration, sample heating has been shown to 
change the state of aggregation.11,12 However, no structural information has been collected to 
characterize these states systematically. To understand structural properties of the various states 
of aggregation and the heterogeneous nature of AmB, samples prepared under varying conditions 
were characterized using SSNMR spectroscopy and compared to determine which sample 
preparation condition leads to homogeneity. 
  
4.4 Materials and Methods 
4.4.1 Amphotericin B purification 
Prior to any sample preparation for SSNMR or powder diffraction, all AmB was purified 
using preparative HPLC purification as previously described.16 Crude natural abundance (NA) 
AmB was acquired either from AK Scientific, Inc. (Union City, CA) or Bristol-Myers Squibb 
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Company (New York, NY). Isotopically 13C labeled AmB was expressed and purified as 
described in Chapter 3. 
4.4.2 Sample preparation of NA AmB methanol film 
Preparative HPLC pure AmB was resuspended with optima MeOH and was bath 
sonicated briefly. MeOH was then removed by rotary evaporation before analysis. 
4.4.3 Sample preparation of NA AmB aggregate heated in buffer 
 Purified AmB (19.5 mg) was dissolved in DMSO (10 mg/mL) and bath sonicated briefly 
to dissolve the material. AmB was then precipitated out of solution by adding 20 mL of 10 mM 
Hepes-NaOH, pH 7.0 at room temperature. The sample was then heated for 1 hour (80 ºC water 
bath) then allowed to cool on the benchtop for 1 hour. The sample was then transferred into a 50 
mL conical centrifuge tube and was centrifuged (Eppendorf A-4-62, 3,200 x g, 10 min., 4 ºC). 
The supernatant was decanted and material was transferred into a 3 mL polycarbonate 
ultracentrifuge tube (Beckman Coulter 349622) using cold 10 mM Hepes buffer, pH 7.0. The 
sample was then pelleted (Beckman Coulter TLA 100.3, 345,000 x g for 45 min., 4 ºC). The 
supernatant was then removed and the material was packed into a 3.2 mm standard wall rotor. 
4.4.4 Sample preparation of NA AmB aggregate heated in DMSO 
 A 10 mg/mL solution of AmB in DMSO (~ 30 mg AmB) was heated to 80 ºC in a water 
bath. After one hour of heating, 10 mM Hepes buffer, pH 7.0 (80 ºC) was added in the following 
increments: 3.0 mL added drop wise, 3.0 mL added 300 µL at a time, 4.0 mL added 500 µL at a 
time, 5.0 mL added 1 mL at a time, 15.0 mL added at once. The vial was then taken out of the 
water bath and left on the benchtop to cool (~ 1 hour). The cooled sample was then transferred 
into a 50 mL conical centrifuge tube and was centrifuged (Eppendorf A-4-62, 3,200 x g, 15 min., 
4 ºC). The supernatant was decanted and material was transferred into a 2 mL microcentrifuge 
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tube using 1 mL of cold buffer. The sample was pelleted (Eppendorf F45-30-11, 20,800 x g, 15 
min., 4 ºC). The supernatant was aspirated off and the pellet was resuspended in 1 mL of buffer. 
The sample was then pelleted again (Eppendorf F45-30-11, 20,800 x g, 15 min., 4 ºC), 
supernatant aspirated, and the pellet was packed into a 3.2 mm standard wall rotor. 
4.4.5 Sample preparation of 25% U-13C AmB aggregate heated in DMSO 
 A mixture of NA (15.2 mg) and U-13C (4.8 mg) AmB was dissolved in DMSO (10 
mg/mL) and heated to 80 ºC for 1 hour in a water bath. After one hour of heating, 10 mM Hepes 
buffer, pH 7.0 (80 ºC) was added in the following increments: 5.0 mL added 200 µL at a time, 
5.0 mL added 500 µL at a time, 5.0 mL added 1 mL at a time, 5.0 mL added at once. The sample 
continued to sit in the 80 ºC water bath for another hour before it was taken out and left on the 
benchtop to cool (~1 hour). The sample was then transferred into a 50 mL conical centrifuge 
tube and was centrifuged (Eppendorf A-4-62, 3,200 x g, 30 min., 4 ºC). The supernatant was 
decanted and material was transferred into a 2 mL microcentrifuge tube using 1 mL of cold 
buffer. The sample was pelleted (Eppendorf F45-30-11, 10,600 x g, 30 min., 4 ºC). The sample 
was then resuspended in another 1 mL of cold buffer and pelleted in the same way. This washing 
step was repeated once more before the material was packed into a 3.2 mm standard wall rotor. 
4.4.6 Sample preparation of 100% U-13C AmB aggregate heated in DMSO 
 U-13C AmB (5 mg) was dissolved in DMSO (10 mg/mL) and heated to 80 ºC for 1 hour 
in a water bath. After one hour of heating, 10 mM Hepes buffer, pH 7.0 (80 ºC) was added in the 
following increments: 1.25 mL added 50 µL at a time, 1.25 mL added 125 µL at a time, 1.25 mL 
added 250 µL at a time, 1.25 mL added at once. The sample continued to sit in the 80 ºC water 
bath for another hour before it was taken out and left on the benchtop to cool (~1 hour). The 
sample was then transferred into a 15 mL conical centrifuge tube and was centrifuged 
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(Eppendorf A-4-62, 3,200 x g, 30 min., 4 ºC). The supernatant was decanted and material was 
transferred into a 1.7 mL microcentrifuge tube using 1 mL of D2O. The sample was pelleted 
(Eppendorf F45-30-11, 10,600 x g, 30 min., 4 ºC). The sample was then resuspended in another 
1 mL of D2O and pelleted in the same way. This washing step was repeated once more before the 
material was packed into a 1.6 mm rotor. 
4.4.7 SSNMR data collection 
 Cross polarization 1D spectra for the NA samples were collected on a 600 MHz 1H 
frequency Varian Infinity Plus spectrometer equipped with a triple resonance 1H/13C/15N 3.2 mm 
T3 probe or a 500 MHz 1H frequency Varian NMR Systems spectrometer equipped a triple 
resonance 1H/13C/15N 3.2 mm Balun probe. Pulse widths for 1H and 13C were 2.3 µs and 2.4-3.0 
µs respectively and SPINAL-64 decoupling21 was used at ~80 kHz. The variable temperature set 
point was 10 ºC and the MAS rate was 10 kHz. 
Two and three-dimensional 13C correlation spectra using either DARR22,23 or SPCn24 
mixing of the 25% U-13C AmB sample were collected on a 600 MHz 1H frequency Varian 
Infinity Plus spectrometer equipped a triple resonance 1H/13C/15N 3.2 mm T3 probe. The 1H 
pulse width was 2.2 µs, the 13C pulse width was 2.5 µs and 80 kHz of SPINAL-64 decoupling21 
was used. The MAS rate was 12.5 kHz and the variable temperature was set at 10 ºC.  
Two and three-dimensional 13C correlation spectra using either DARR,22,23 SPCn,24 or 
PAR25 mixing of the 100% U-13C AmB sample were collected on either a 500 MHz 1H 
frequency Varian NMR Systems spectrometer equipped a quadruple resonance 1H/13C/2H/15N 
1.6 mm Fast MAS probe or a 750 MHz 1H frequency Varian NMR Systems spectrometer 
equipped a triple resonance 1H/13C/15N 1.6 mm Fast MAS probe. The 1H pulse width was 1.6-1.8 
µs, the 13C pulse width was 1.6-1.8 µs and ~100 kHz of SPINAL-64 decoupling21 was used. Data 
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was collected with a variable temperature set point of either 0 ºC or -15 ºC and the MAS rates 
ranged from 12.5 kHz to 33 kHz. 
In all cases, chemical shifts were referenced externally to adamantane (downfield peak 
set to 40.48 ppm).26 Spectra were processed using NMRPipe27 or VnmrJ 3.2. 13C 1D spectra 
were processed with 10 Hz line broadening and multidimensional spectra were processed with 
100 Hz line broadening. Analysis was conducted using Sparky.28 
4.4.8 Powder diffraction data collection 
 Powder diffraction data were collected at the George L. Clark X-Ray Facility (University 
of Illinois at Urbana-Champaign). Small portions of AmB material were submitted for capillary 
X-ray powder diffraction analysis. 
 
4.5 Results and Discussion 
4.5.1. Powder diffraction and solid-state NMR spectroscopy of natural abundance AmB 
 To structurally assess the variation in sample heterogeneity and the changes that occur 
between the various preparations, powder diffraction and SSNMR data were collected for a 
series of NA AmB prepared in different ways (Fig 4.2). As a control, the first sample prepared 
was a MeOH film. In this sample, preparative purified AmB was resuspended in MeOH and the 
solvent was evaporated, leaving a film of material. This sample was prepared with no addition of 
water and only mild heating (from rotary evaporator; 30 ºC). A portion of the material was used 
for powder diffraction while the remainder of the material was packed into a SSNMR rotor with 
no hydration to collect a one-dimensional 13C spectrum (13C 1D). 
 The powder diffraction spectrum of the MeOH film sample shows a number of peaks, 
which are indicative of a higher level of molecular order of the sample (Fig 4.2a). Thus, one 
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would expect the SSNMR data to have narrow linewidths. However, contrary to expectations, 
the 13C 1D exhibits broad peaks. This is typically indicative of sample heterogeneity. One reason 
why the 13C 1D is broader may be the lack of water in the sample, which has been a factor in 
spectral resolution of other molecules.17,18,19,20 
 In the second sample, AmB was first dissolved into DMSO and precipitated out of 
solution using buffer before being heated. Once heated and cooled, AmB was centrifuged and 
powder diffraction data as well as a 13C 1D was collected (Fig 4.2b). Similar to the MeOH film, 
the powder diffraction data shows a number of peaks that indicate high order. The two samples 
also have a similar powder diffraction fingerprint. However, unlike the powder diffraction data, 
the 13C 1D is very different. Unlike the MeOH sample, this buffer heated aggregate has 
significantly better line widths, where individual peaks can be resolved in regions where no 
resolution was observed in the MeOH sample (e.g. 60 ppm to 10 ppm region). Furthermore, we 
are able to determine that each carbon site of the molecule gave multiple resonances, indicating 
that the molecule was in multiple conformations or states. 
 Given the tendency for AmB to form multiple states, we then tried to prepare a sample 
where there would be a single conformation. In this sample AmB was dissolved in DMSO and 
heated to 80 ºC before being precipitated out of solution with buffer at high temperature. The 
sample was cooled on benchtop, pelleted, and characterized using the same methods (Fig 4.2c). 
This method resulted in a powder diffraction spectrum that was very different from the other two 
samples. The minimal number of features shown in this spectrum indicates that AmB in this 
particular sample is amorphous. The 13C 1D also shows some differences, where the peaks are 
not as broad as in the MeOH sample. Furthermore, the 13C 1D has fewer peaks (e.g. region near 
100 ppm), which is indicative of fewer states. Thus, we were able to determine a method that 
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would result in a more homogenous sample, which was then used to make a set of isotopically 
labeled samples for further SSNMR studies. 
4.5.2. Multidimensional SSNMR spectra of aggregated AmB  
 To perform multidimensional SSNMR studies of AmB, two U-13C AmB samples were 
prepared using the high temperature precipitation method. The first sample was a 25% U-13C 
AmB sample (diluted in a background of NA AmB), where the sample was washed with a 
protonated buffer and was packed into a 3.2 mm standard wall rotor. The second sample was a 
100% U-13C AmB sample, where the sample was washed with D2O and was packed into a 1.6 
mm fast MAS rotor. 
As shown in Fig. 4.3a, the one- to two-bond correlation 13C-13C two-dimensional 
correlation (13C-13C 2D) spectrum of the 25% sample contains indicates that there are at least 
two states present. This is evident by the two sets of peaks observed for the carbon 8-9 
correlation near the diagonal. A cross peak in the 70 ppm to 80 ppm region of a one-bond 
correlation spectrum would correspond to a correlation between an alcohol carbon that is directly 
bonded to another alcohol carbon. Since carbon 8 and carbon 9 are the only directly bonded 
alcohol carbons, it can be concluded that multiple peaks in this region come from multiple states 
of carbon 8 and carbon 9. 
By performing a backbone walk from the carbon 8-9 cross peak, chemical shift 
assignments were determined for resolved carbons. Table 4.1 reports the chemical shift 
assignments for the carbons in this sample. The analysis showed two resonances for most 
carbons throughout the molecule, confirming that AmB forms 2 different states. 
 When similar spectra were collected on the 100% U-13C AmB sample (Fig. 4.3b), 
different results were observed. In general, the 100% U-13C AmB exhibits much broader line 
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widths. For example, the line width of the carbon 8 – carbon 9 peak for the state B (8-9B) has a 
line width in ω1 of 380 Hz and line width in ω2 of 350 Hz (processed with 100 Hz line 
broadening) compared to line width in ω1 of 200 Hz and line width in ω2 of 220 Hz observed in 
the 25% U-13C AmB sample (processed identically). Likewise other peaks that were isolated and 
assignable in the 25% U-13C AmB sample, such as 8-7B, 3-2A, and 5-4B, are overlapped with 
other signal and are not uniquely assigned. 
The sharper line widths of the first labeled sample indicate that the sample forms multiple 
states but the multiple states are homogeneous. The greater line widths of the latter sample 
indicate that the sample is heterogeneous. The molecules in the sample may have adopted 
multiple states that are in similar chemical environments, leading to similar chemical shifts. 
Since the chemical shifts are similar but not identical, an overlap of signals occur leading to 
broad peaks in the spectrum. Chemical shift assignments were also performed for this sample in 
a similar manner to the 25% U-13C sample. Since the line widths are significantly greater, the 
reported chemical shifts in Table 4.2 represent an average of the multiple states present.  
 The differences between the two samples are most likely due to differences in sample 
preparation. Though factors such as concentration of solutions and precipitation method were 
adjusted to accommodate the difference in scale, other conditions such as slight differences in 
the purity of the analyte or solvents may have also contributed to the differences. This further 
confirms the heterogeneous nature of AmB and signifies that more detailed controls are 
necessary to ensure consistent production of the desired aggregate.  
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4.6 Figures and Tables 
 
Fig. 4.1. Two-dimensional structure of amphotericin B with carbon numbering. The mycosamine carbon number is 
denoted with a (’). 
 
 
 
 
 
Fig. 4.2. Powder diffraction spectrum and 13C cross polarization SSNMR 1D spectrum of (a) NA methanol film 
sample, (b) NA buffer heated aggregate, and  (c) NA DMSO heated aggregate of AmB indicate that AmB adopts 
multiple states dependent upon sample preparation. The 1D NMR spectra were collected at 600 MHz 1H frequency 
(heated aggregates) or 500 MHz 1H frequency (MeOH film). The spectra were signal averaged for 13.5 hours 
(MeOH film), 34 hours (buffer heated aggregate), and 68 hours (DMSO heated aggregate) and all spectra were 
processed with 10 Hz line broadening. 
 61 
 
Fig. 4.3. 13C-13C two-dimensional spectra of SPCn spectra of the 25% U-13C AmB sample (a) and the 100% U-13C 
AmB sample (b). Though both samples were prepared using a similar technique, the spectra show great differences 
in line widths. Data on the 25% U-13C AmB sample was collected 600 1H frequency using SPC7 mixing (q = 56) 
and was signal averaged for 57.5 hours. The 100% U-13C AmB spectrum was collected at 750 1H frequency using 
SPC5 mixing (q = 40) and was signal averaged for 49 hours. Both spectra were processed with 100 Hz line 
broadening. 
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Table 4.1: 13C Chemical shifts of 25% U-13C AmB aggregate 
Carbon Number State A Chemical Shift (ppm) State B Chemical Shift (ppm) 
1 175.9 174.1 
2 41.5 45.6 
3 71.3 71.6 
4 44.6 45.8 
5 74.5 78.3 
6 36.1 40.1 
7 33.1 37.5 
8 74.7 77.0 
9 80.0 79.1 
10 41.6 42.9 
11 73.0 72.8 
12 47.2 48.2 
13 100.5 100.8 
14 47.2 45.8 
15 69.6 69.9 
16 62.4 60.9 
17 68.7 68.5 
18 Not Determined 40.5 
34 45.9 45.9 
35 79.0 79.0 
36 43.0 43.0 
37 74.6 74.6 
38 20.6 19.5 
39 13.2 12.9 
40 23.6 23.7 
41 182.4 183.2 
1' 101.0 Not Determined 
2' 71.1 Not Determined 
3' 58.2 Not Determined 
4' 71.5 Not Determined 
5' 75.8 Not Determined 
6' 20.3 Not Determined 
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Table 4.2: 13C Chemical shifts of 100% U-13C AmB aggregate 
Carbon Number Chemical Shift (ppm) 
1 176.4 
2 42.8 
3 72.0 
4 44.0 
5 75.3 
6 36.4 
7 32.2 
8 76.3 
9 79.1 
10 42.3 
11 72.2 
12 48.9 
13 100.5 
14 45.7 
15 69.2 
16 62.5 
17 68.6 
18 39.8 
19 78.7 
34 45.8 
35 79.4 
36 42.7 
37 73.1 
38 19.4 
39 14.7 
40 23.1 
41 182.6 
1' 97.2 
2' 70.7 
3' 58.0 
4' 71.4 
5' 75.5 
6' 19.8 
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CHAPTER 5 
Partial 1H chemical shift assignments of an AmB aggregate determined using ultra high 
field and ultra fast magic angle spinning solid-state NMR spectroscopy 
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5.2 Abstract 
 Magic angle spinning solid-state NMR spectroscopy has become an extremely powerful 
technique to study the structures and dynamics of complex systems. The developments of ultra 
high field magnets as well as solid-state NMR probes with fast magic angle spinning technology 
have made the technique more powerful by improving the sensitivity and resolution of NMR 
spectra. This technology has been applied to the structural study of the life saving antifungal 
drug amphotericin B. The 1H chemical shifts of the molecule in a solid form were determined 
and compared to values previously determined by solution NMR. 
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5.3 Introduction 
 Significant improvements in high-resolution magic angle spinning (MAS) solid-state 
NMR spectroscopy (SSNMR) technology1 have enabled the structural studies of complex 
biological systems such as membrane proteins2 and fibrils.3 Two particular advancements 
include the development of ultrahigh field (UHF) magnets and ultra fast magic angle spinning 
(UFMAS).4-9 With UHF magnets, the magnetic field (B0) is increased. When B0 increases,10,11 
sensitivity increases linearly and resolution increases by a factor of B07/4. Therefore, the 
development of UHF magnets have allowed for the improved quality of NMR data by enhancing 
sensitivity and resolution. 
UFMAS technology also allows for higher sensitivity and resolution. Despite the high 
sensitivity of 1H detection in NMR, biomolecular solid-state NMR has been  historically limited 
to 13C-detected experiments because of the large dipolar couplings associated with 1H. MAS at 
~10 kHz is not sufficient to remove the 1H dipolar coupling, leading to broad signals in the 1H 
dimension. However, fast MAS (>30 kHz) allows for adequate averaging of the 1H dipolar 
coupling in the case of deuterated proteins with a small fraction of 1H sites exchanged back (such 
as amide protons), which leads to better resolution in the 1H dimension. For uniformly 
protonated samples such as 13C-labeled amphotericin B (AmB), MAS rates exceeding 100 kHz 
are necessary in order to average the many strong (~30 kHz) homonuclear 1H-1H couplings. By 
applying such technique, one can utilize the high sensitivity of 1H detection with no significant 
compromise in resolution. 
 Given the advantages of UHF and UFMAS NMR, these techniques were applied to the 
structural study of AmB. Previously, carbon chemical shifts were determined for a few different 
states of AmB (Chapter 4). However, to determine long range correlations of the molecule, UHF 
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and UFMAS SSNMR experiments were applied. Herein, we present UHF/UFMAS data that has 
been collected on AmB and the 1H chemical shift assignments of the aggregate. 
 
5.4 Materials and Methods 
5.4.1 Sample preparation 
 The sample preparation used for the experiments collected at 33 kHz MAS and 750 MHz 
1H frequency was previously described Chapter 4 (100% U-13C sample). For the 1 GHz 1H 
frequency experiments, 3 mg U-13C AmB was dissolved in DMSO (10 mg/mL) and heated to 80 
ºC for 1 hour in a water bath. After one hour of heating, 10 mM Hepes buffer, pH 7.0 (80 ºC) 
was added in the following increments: 0.75 mL added 30 µL at a time, 0.75 mL added 75 µL at 
a time, 0.75 mL added 150 µL at a time, 0.75 mL added at once. The sample was then kept in the 
80 ºC water bath for another hour then taken out and allowed to cool on the benchtop for 1 hour. 
The suspension was then transferred into a 15 mL conical centrifuge tube and was centrifuged 
(Eppendorf A-4-62, 3,200 x g, 30 min., 4 ºC). The supernatant was decanted and material was 
transferred into a 1.7 mL microcentrifuge tube using 1 mL of D2O. The sample was pelleted 
(Eppendorf F45-30-11, 10,600 x g, 30 min., 4 ºC). The supernatant was aspirated off and the 
sample was once again resuspended in 1 mL of D2O and pelleted in the same way. This washing 
step was repeated once more before the material was ready to be packed. 
5.4.2 NMR data collection 
 Data at 33 kHz MAS were collected on a 750 kHz 1H frequency Varian NMR Systems 
spectrometer equipped with a triple resonance 1H/13C/15N 1.6 mm Fast MAS probe. The 1H pulse 
width was 1.6 µs and the 13C pulse width was 2.3 µs and the variable temperature set point was -
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15 ºC. SPINAL-64 decoupling12 was used at approximately 70 kHz. The 13C-1H two-dimensional 
correlation spectrum1 was collected using MISSISSIPPI solvent suppression.13 
 Data collection at 60 kHz MAS and 111 kHz MAS rates was performed on a 1 GHz 1H 
frequency Bruker Avance III equipped with a 0.7 mm HCN probe at the Centre de RMN à Très 
Hauts Champs (Institut des Sciences Analytiques - Ecole Normale Supérieure de Lyon). The 1H 
pulse width was 1.18 µs and the 13C pulse width was 3.1 µs. The variable temperature set point 
was 11.85 ºC at 40 kHz and -13.15 ºC at 111 kHz. All spectra were collected with MISSISSIPPI 
solvent suppression.13 
The 13C-1H two-dimensional spectra were processed with 100 Hz of line broadening in 
both dimensions. The 13C-13C-1H spectrum was processed with 200 Hz of line broadening in 
each dimension and the 13C-13C-[1H]-1H spectrum was processed with 225 Hz line broadening in 
the direct dimension and 200 Hz of line broadening in the indirect dimensions. 
Chemical shifts were referenced externally to adamantane (downfield peak set to 40.48 
ppm).14 Spectra were processed using NMRPipe15 and analyzed using Sparky.16 
 
5.5 Results and Discussion 
5.5.1 Effect of field and MAS rate on AmB 1H line widths 
 UHF and UFMAS experiments were first conducted on AmB at 750 MHz 1H frequency 
instrument with an MAS rate of 33 kHz. Using a 100% U-13C sample (same sample used in 
chapter 4), a two-dimensional 13C-1H correlation spectrum1,13 (Fig. 5.1a) was collected. In this 
spectrum, we were able to observe a number of resonances corresponding to the various portions 
of the molecule. The lack of resolved peaks in the spectrum is due to the large number of atoms 
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in the AmB molecule within similar chemical environments. However, we are able to resolve 
two peaks, 16C-H and 3’C-H, where the 1H line widths are 660 Hz and 680 Hz respectively. 
 To investigate the advantages of collecting data at higher magnetic field and faster MAS 
rates, we prepared a similar sample of U-13C AmB for data collection at 1 GHz 1H frequency and 
MAS rates above 40 kHz. A two-dimensional 13C-1H correlation was first collected at a MAS 
rate of 60 kHz (Fig. 5.1b). In this spectrum, we observe similar fingerprint regions of the 
spectrum as well as the same two resolved peaks as compared to the data collected at 750 MHz 
1H frequency. In general, the 1H line widths are narrower. For example, the 1H line widths of the 
polyene peak in the 33 kHz spectrum is approximately 6 ppm. In this spectrum, the line width is 
reduced to 3 ppm. We note that this peak includes both homogeneous and inhomogeneous 
contributions since there are several polyene protons with similar but not identical chemical 
shifts. Furthermore, the 1H line widths of the two resolved peaks (16C-H: 470 Hz; 3’C-H: 460 
Hz) were narrowed by approximately 200 Hz. 
 The MAS rate was then raised to 111 kHz and the same 13C-1H correlation spectrum was 
collected (Fig. 5.1c). As expected, the line widths appear to be sharper and the measured line 
widths of the two resolved peaks (16C-H: 360 Hz; 3’C-H: 280 Hz) were 100 Hz to 200 Hz 
narrower than the line widths at 60 kHz MAS and nearly 400 Hz narrower than the spectra 
collected at 33 kHz MAS / 750 MHz 1H frequency.  
5.5.2 Three-dimensional 13C-13C-1H correlation spectra 
 Previously, 13C chemical shift assignments were made on an aggregated form of AmB 
(Chapter 4). UHF and UFMAS technology allows for the acquisition of resolved 1H NMR data 
in the solid state. Three-dimensional spectra were collected to perform 1H chemical shift 
assignments. 
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The first spectrum collected was a 13C-13C-1H correlation spectrum. In this pulse 
sequence (Fig. 5.2a), magnetization on 13C is enhanced using cross polarization (CP) and 
frequency-labeled in the t1 evolution period before 13C-13C mixing. For 13C-13C mixing, a 
TOCSY17 type of mixing using 17 ms of 1H WALTZ decoupling18 was used. The 13C 
magnetization was then subjected to a t2 evolution period before the magnetization is transferred 
back to 1H, using CP, for detection. The result is a three-dimensional spectrum where the two 
indirect dimensions are 13C and the direct dimension is 1H. Since there is a lack of 1H mixing and 
the CP contact time is short, the correlations between 13C and 1H in this spectrum can be 
assumed to be a correlation between directly bonded 13C-1H pairs. 
Figure 5.2b shows two 2D planes of the spectrum. On the left panel, correlations are 
observed between C3’ and neighboring carbons C2’, C4’, and C5’ and the respective protons that 
are attached to those carbons. On the right, there is a correlation between C16 and C15 and the 
directly attached protons. Since the 13C chemical shifts were previously assigned, this experiment 
allowed the assignments of 1H chemical shifts throughout the molecule, with the exception of the 
degenerate polyene region. 
The second experiment performed was a 13C-13C-[1H]-1H correlation spectrum. This 
pulse sequence (Fig. 5.3a) is similar to the first pulse sequence, but includes an additional 1H-1H 
mixing period immediately before detection. This results in a spectrum that correlates a given 
carbon to neighboring carbons as well as neighboring protons. This allows for the conformation 
of 1H chemical shift assignments and can provide semi-quantitative distance information 
between protons. 
In Fig. 5.3b, the 3’ and 16 carbon planes of this spectrum are plotted (same spectral 
region as in Fig. 5.2b). As expected, the same correlations observed in the 13C-13C-1H spectrum 
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are present in this spectrum. However, with the extra 1H-1H mixing period, there are a number of 
other peaks correlating a carbon with other neighboring protons. Thus, we are able to verify the 
proton assignments. 
5.5.3 1H chemical shift assignments 
AmB contains a total of 73 protons. Of these protons 10 are hydroxyl protons, 3 protons 
are apart of the amino group on the mycosamine, and 14 are apart of the polyene chain. Since 
these protons are either not detected in the spectra or are not uniquely resolved in the spectra, 
these protons cannot be uniquely assigned. AmB also contains 4 methyl groups. Each methyl 
group contains 3 protons that are isotropically averaged. Therefore, the 12 protons in these 
methyl groups result in only 4 uniquely assignable resonances. Given the physical properties of 
these protons and assuming there is only one state of the AmB molecule, only 38 resonances 
would be expected. Of the 38 expected resonances, 31 assignments were made. Table 5.1 lists 
the assignments.  
The assigned chemical shifts were then compared to previously published 1H chemical 
shifts that were determined by solution NMR spectroscopy under three different conditions.19-21 
To compare the solids shifts to these solution shifts, the chemical shifts were converted to the 
TMS scale.22 Then, the differences in shifts were determined between the solid shifts and each 
set of solution shifts and the absolute value of the difference were plotted for each site (Fig. 5.4).  
Most of the differences are less than 0.5 ppm with the exceptions being protons 5, 18b, 
19, as well as a few of the mycosamine protons. The differences in these exceptions range from 
0.6 ppm to over 1 ppm. Minor differences may be due differences in molecular order between 
each molecule in the solid form versus an isotropic solution. However, the larger differences 
observed at specific sites of the molecule may indicate potential differences of conformation of 
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the molecule between the solid and solution states. In particular, differences at 18b, 19, and the 
mycosamine may indicate a difference in mycosamine orientation with relation to the 
macrocycle in the solid form. 
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5.6 Figures and Tables 
 
Fig. 5.1. Two-dimensional 13C-1H spectra1 collected at (a) 33 kHz MAS and 750 MHz 1H frequency, (b) 60 kHz 
MAS and 1 GHz 1H frequency, and (c) 111 kHz MAS and 1 GHz 1H frequency. Spectra were processed with 100 
Hz line broadening. As field strength and MAS rates were increased, the 1H line widths noticeably decreased. The 
1H linewidth for the 16C-H peak went from 660 Hz to 470 Hz to 360 Hz and the 1H linewidth for the 3’C-H 
decreased from 680 Hz to 460 Hz down to 280 Hz. 
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Fig. 5.2. Three-dimensional 13C-13C-1H pulse sequence. (a) Schematic of the pulse sequence. 1H magnetization is 
transferred to 13C using cross polarization. After a t1 evolution period, the TOCSY type of mixing occurs on 13C. A 
t2 evolution period occurs after mixing and water suppression is performed before the magnetization is transferred 
back from 13C to 1H before detection. (b) Strips of a resulting spectrum of this pulse sequence applied to an AmB 
sample showing correlations from C3’ and C16 to neighboring carbons and protons. Data was collected with 17 ms 
WALTZ decoupling for 13C-13C mixing. The spectrum was processed with 200 Hz line broadening in each 
dimension. 
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Fig. 5.3. Three-dimensional 13C-13C-[1H]-1H pulse sequence. (a) Schematic of the pulse sequence. 1H magnetization 
is transferred to 13C using cross polarization. After a t1 digitization period, the TOCSY type of mixing occurs on 13C. 
A t2 evolution period occurs after mixing and water suppression is performed before the magnetization is transferred 
back from 13C to 1H. 1H magnetization is then mixed using RFDR before detection. (b) Strips of a resulting spectrum 
of this pulse sequence applied to an AmB sample showing correlations from C3’ and C16 to neighboring carbons 
and protons. The additional proton mixing allows for longer-range correlations allowing for confirmation of 
assignments. Data was collected with 17 ms WALTZ decoupling for 13C-13C mixing and 1 ms of RFDR mixing. The 
spectrum was processed with 225 Hz line broadening on the direct dimension and 200 Hz in each indirect 
dimension. 
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Fig. 5.4. Difference of 1H chemical shift of resolved 1H sites. The 1H chemical shifts were compared between the 
determined solid aggregate form and the published solution data.19-21 The solids chemical shifts were converted to 
the TMS scale and the absolute value of the difference between the solids and solution shifts were plotted for each 
site. The greatest differences are localized at protons 5, 18b, 19, and the mycosamine, indicating a potential 
difference in structure caused by the molecular order in the solid form. 
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Table 5.1: 1H Chemical shifts of an AmB aggregate 
Proton Identity Chemical Shift on DSS Scale (ppm) Chemical Shift on TMS Scale (ppm) 
2a 2.16 2.14 
2b 1.82 1.82 
3 4.23 4.23 
4a Not Determined Not Determined 
4b Not Determined Not Determined 
5 4.44 4.44 
6a 1.14 1.14 
6b Not Determined Not Determined 
7a 1.08 1.08 
7b 1.71 1.71 
8 Not Determined Not Determined 
9 3.45 3.45 
10a Not Determined Not Determined 
10b Not Determined Not Determined 
11 4.38 4.38 
12a 1.87 1.87 
12b 1.27 1.27 
14a Not Determined Not Determined 
14b 2.17 2.17 
15 4.24 4.24 
16 2.07 2.07 
17 4.22 4.22 
18a 1.34 1.34 
18b 1.10 1.10 
19 3.48 3.48 
34 2.15 2.15 
35 3.43 3.43 
36 1.48 1.48 
37 5.41 5.41 
38 (methyl) 1.21 1.21 
39 (methyl) 1.05 1.05 
40 (methyl) 1.14 1.14 
1' 4.78 4.78 
2' 4.20 4.20 
3' 3.44 3.44 
4' 3.52 3.52 
5' 3.46 3.46 
6' (methyl) 1.29 1.29 
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CHAPTER 6 
Aggregated amphotericin B adopts two distinct conformations 
 
6.1 Notes and Acknowledgements 
The National Institutes of Health (R01-GM112845) and the University of Illinois 
Centennial Scholars Award (to C.M.R.) has supported this work. The author wishes to thank Dr. 
Alexander Greenwood for performing ab initio chemical shift calculations and NMR data 
analysis and Dr. Agnieszka Lewandowska for developing the sample preparation method. The 
author would also like to thank Mr. Jordan Holler for the expression and purification of the 
amphotericin B used in this study. The author also would like to thank Prof. Chad Rienstra for 
important discussion and research guidance and data collection. 
 
6.2 Abstract 
 Amphotericin B remains to be one of the most important and effective treatments for life-
threatening systemic fungal infections. However, the toxicity of the drug continues to limits the 
use of the drug. AmB has been shown to form multiple aggregation states, making it challenging 
to conduct structural studies of the molecule. We developed a reproducible method to isolate a 
homogeneous aggregate of AmB and using state of the art magic angle spinning solid-state NMR 
spectroscopy, the structure of aggregated AmB was studied. It was discovered that AmB forms 
two different states that form an antiparallel dimer. 
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6.3 Introduction 
 Amphotericin B (AmB; Fig. 6.1a) has long been used as an antifungal treatment for life-
threatening systemic fungal infections and remains the gold standard for fungal infection 
treatment.1 However, the toxicity of the drug continues to pose a challenge for treatment, 
especially in immunocompromised patients where the mortality rate of fungal infection patients 
exceeds 50% even with treatment.2,3 
 The long-standing model for AmB activity has been the ion channel model.4 However, it 
was recently shown that AmB forms a large extramembranous sterol sponge that extracts sterols 
from the fungal cell membranes leading to cell death.5 The lack of high-resolution structural 
information of the AmB sterol sponge has limited progress in developing analogs of AmB. 
Structural studies of AmB have relied heavily on the crystal structure of the N-Iodoacetyl 
derivative of AmB (AmB-I).6,7 In the crystal structure of AmB-I, the molecules pack in an 
antiparallel fashion and the polyol chain of the molecule adopts a trans conformation. However, 
since AmB has been shown to have a propensity for aggregation and does not crystallize,8-13 
there remains a question of whether or not the AmB-I crystal structure is representative of the 
active state of AmB. 
 To elucidate the structure-function relationship of AmB, we have conducted a study of 
the structure of a homogenous and active AmB aggregate using magic angle spinning (MAS) 
solid-state NMR spectroscopy (SSNMR). We first developed a sample preparation method to 
consistently produce a homogeneous aggregate of AmB. Then, using isotopically 13C-enriched 
AmB, solid-state NMR spectra were collected and structure calculations were performed, 
resulting in a new structural model of AmB within the aggregate. Specifically, the polyol moiety 
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of the AmB aggregate adopts two different conformations and that the two states pack 
macroscopically as an antiparallel dimer. 
 
6.4 Materials and Methods 
6.4.1 AmB expression and purification 
Natural abundance AmB was purchased from AK Scientific, Inc. (Union City, CA) and 
was purified using preparative HPLC purification as previously described.5 Isotopically labeled 
U-13C AmB was expressed by growing cultures of Streptomyces nodosus as previously done.5 
AmB was extracted from the cultures after the cells were spun down (8,000 x g, 4 ºC, 15 min). 
The supernatant was then removed from the cell pellets. The water from the media was removed 
by either rotary evaporation or lyophilization. AmB was extracted from the dried media 
components by resuspending the material in methanol, pelleting out the debris, and collecting the 
solution of crude AmB in methanol; this process was repeated three times. The solvent was then 
removed by rotary evaporation and was stored at -80 ºC before purification. AmB was extracted 
from the cell pellets by homogenizing the dried cells in DMSO. The DMSO-cell mixture was 
then pelleted (8,000 x g, 4 ºC for 15 min) and the supernatant was collected; this process was 
repeated three times. The DMSO was removed from the crude AmB by lyophilization and the 
crude AmB was stored at -80 ºC before purification. 
Crude AmB was first subjected to purification by medium pressure liquid 
chromatography. The crude material was first adsorbed onto Celite 545 by first resuspending the 
material in a minimal amount of N,N-Dimethylformamide then adding Celite 545 directly into 
the flask. Methanol was then added to the mixture and the mixture was then rotary evaporated. 
The addition of Celite and methanol and rotary evaporation was repeated several times until the 
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sample had the consistency of a fluffy yellow powder. The material was then kept under high 
vacuum overnight. A CombiFlash® Rf system (Teledyne Isco, Lincoln, NE) using reverse phase 
C-18 silica gel as the column resin was used to perform the purification. The following gradient 
using 0.1% formic acid in water (solvent A) and methanol with 0.1% formic acid (solvent B) was 
used: 95% solvent A for 5 min.; ramp from 5% to 100% solvent B over 10 min.; 100% solvent B 
for 10 min at a flow rate of 30 mL/min. Fractions after 80% solvent B and above were collected 
and the solvent was removed using rotary evaporation. Residual formic acid was removed from 
the sample by resuspending and bath sonicating the solid sample in water and rotary evaporating 
the sample, azeotroping with excess toluene at least three times. The material was placed under 
high vacuum overnight and the material was then subjected to HPLC purification as previously 
done.5 
6.4.2 SSNMR sample preparation 
 AmB was dissolved in a minimal amount of DMSO and the material was diluted with 10 
mM Hepes buffer, pH 7.0 to a final concentration of 1 mM. The sample was then heated to 80 ºC 
for 1 hour. After heating, the sample was placed into a bath sonicator for 30 min and was then 
allowed to cool on the benchtop for another 30 min. The sample was then pelleted (260,000 x g, 
4 ºC, 40 min) in a 1.7 mL ultracentrifuge tube using a TLA 100.3 centrifuge rotor (Beckman 
Coulter Item No. 349481). The supernatant was removed and the material was resuspended in a 
small amount of buffer and transferred to 200 µL ultracentrifuge tubes. The material was pelleted 
(280,000 x g; 4 ºC, 1 hour) using a TLA-100 centrifuge rotor and the material was packed into a 
SSNMR rotor using a rotor packing device.14 UV-Vis spectra were collected a various points in 
the sample preparation to track the material species. Spectra were collected using a NanoDrop 
2000c (Thermo Fisher Scientific, Wilmington, DE). 
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6.4.3 NMR data collection 
 Data collection for the cross polarization one-dimensional spectrum of the natural 
abundance sample was collected on AmB was performed on a 600 MHz 1H frequency Varian 
Infinity Plus spectrometer equipped with either a triple resonance 1H/13C/15N 3.2 mm T3 probe. 
The spectrum was collected at an MAS rate of 12.5 kHz and the variable temperature (VT) set at 
0 ºC. The 1H pulse width was 2.5 µs, the 13C pulse width was 3.0 µs, and ~80 kHz of SPINAL-
64 decoupling.15 A 0.16 ms hard echo was used. The spectrum was signal averaged for 
approximately 46 hours and processed with 20 Hz line broadening. 
 Data collection for the U-13C AmB sample was performed on a 600 MHz 1H frequency 
Varian Infinity Plus spectrometer equipped with either a triple resonance 1H/13C/15N 3.2 mm T3 
probe or a triple resonance 1H/13C/15N 3.2 mm Balun probe. The MAS rate was set to 12.5 kHz 
and the pulse widths were 2.3-2.8 µs on 1H and 2.2-3.0 µs on 13C. SPINAL-64 decoupling15 was 
used at ~80 kHz. The 13C-13C two-dimensional (13C-13C 2D) spectra were collected with either 
SPC716 or DARR17,18 mixing. The VT was set to 0 ºC and spectra were processed with 30 Hz 
line broadening. For the temperature series, the cross polarization spectra were processed with 10 
Hz line broadening and the direct polarization spectra were processed with 25 Hz line 
broadening. 
 Chemical shifts were referenced externally to adamantane.19 Spectra were processed with 
NMRPipe20 and spectra were analyzed using Sparky.21 
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6.5 Results and Discussion 
6.5.1 Sample preparation of the homogeneous AmB aggregate 
 A new sample preparation method was devised in order to produce a homogeneous AmB 
aggregate at a quantity large enough to conduct SSNMR experiments. Fig. 6.1b outlines the new 
method of sample preparation, which utilizes a combination of heating and sonication of AmB in 
buffer at a concentration at 1 mM. To determine the level of homogeneity, UV-Visible spectra 
were collected before heating and after the heating/sonication process (Fig. 6.1c) and principal 
component analysis was performed (Aga Lewandowska and Alex Greenwood, unpublished 
results). 
 This sample preparation was first tested using natural abundance AmB and demonstrated 
reproducibility. A cross polarization 13C one-dimensional spectrum (CP1D) was collected (Fig. 
6.1d). One interesting feature of this spectrum is the number of peaks within the carbonyl region. 
AmB contains only two carbonyls, thus, if the sample exhibited only one conformation, two 
peaks would be observed in the carbonyl region. However, at least three peaks are observed in 
that region, indicating that at least one of the carbonyls experience multiple states. 
6.5.2 SSNMR spectra reveal two states of the AmB molecule 
 13C chemical shifts were determined de novo for the AmB aggregate. A uniformly-13C 
labeled (U-13C) AmB sample was prepared and a one-bond correlation 13C-13C 2D spectrum 
using SPC7 mixing16 was collected (Fig. 6.2a). Four resonance frequencies were observed in the 
carbonyl region of this spectrum, which indicates that there are two resonances each for carbonyl 
1 and carbonyl 41. Starting from these positions, chemical shifts were assigned for two states of 
AmB by identifying one- and two-bond correlations throughout the molecule. 
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 The two states were confirmed further by two sets of near-diagonal cross peaks observed 
in the 70 ppm to 80 ppm region of the spectrum (Fig. 6.2b). Chemical shifts within this range 
correspond to alcohol carbons and a cross peak in this region indicates a correlation between two 
directly bonded alcohol carbons. Since carbon 8 and carbon 9 are the only directly attached 
alcohol carbons, the two sets of cross peaks in this region must correspond to the resonances of 
carbon 8 and 9 in the two states of AmB. 
 By performing chemical shift assignments throughout the molecule, two sets of chemical 
shifts were determined. Table I lists the chemical shift assignments of each resolved carbon, 
which exclude the degenerate polyene region. The differences in the chemical shift values were 
calculated between the states and the magnitude of the differences is depicted on the molecule 
(Fig. 6.2c). The largest differences are observed along the polyol, especially at carbons 2, 5, 6, 
and 7, where the chemical shift differences between the two states are greater than 3 ppm. These 
localized differences are likely due to a conformational difference between the two states.22 
 Different conformations of the polyol are in contrast with the AmB-I crystal structure, 
where the polyol chain is in an all-trans conformation. However, the formation of multiple 
conformations of the polyol chain has been observed in various computational studies.23-25 We 
can now conclude with experimental data that AmB does form multiple conformations along the 
polyol. 
6.5.3 Temperature stability of AmB aggregate 
  Two states are present in this aggregate of AmB, but the stability or rigidity of the states 
is unknown. The assignment NMR spectra were collected with the variable temperature set point 
of 0 ºC. However, it was unknown whether the states can exchange near physiological 
temperatures. Thus, a series of CP1D spectra were collected at different variable temperature set 
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points between 0 ºC and 37 ºC (0 ºC, 10 ºC, 20 ºC, ºC, 37 ºC), tracking changes in the fingerprint 
spectrum. The spectra (Fig. 6.3) were collected with the same parameters at each temperature 
and were processed identically. 
 If chemical exchange of the two states occurs, it would be expected that the entire 
spectrum would change, and that in the 13C 1D spectrum these changes would be especially 
notable in the carbonyl region. Specifically, the resolved C1 resonances at approximately 176 
ppm and 174 ppm should coalesce into one peak. However, the peak positions of these carbonyl 
shifts do not change throughout the whole temperature course. Furthermore, at all temperatures, 
the spectra appear to be the same and no significant differences are observed when the spectra 
were overlaid, with minor differences in intensity which can be attributed to slight differences in 
the cross polarization conditions. 
 Direct polarization 13C one-dimensional spectra were also collected at the same 
temperatures. Looking at the resolved carbonyl region (Fig. 6.4), there appears to be no 
significant changes to the intensities and linewidths of the spectra. Likewise, the spectra gave no 
indication of a coalescence of peaks, which argues that AmB is not interconverting states when 
heated. 
6.5.4 Intermolecular interactions between two states 
 To elucidate how the two states of AmB are associated with each other, intermolecular 
contacts were probed. To probe these interactions, a 13C-13C 2D spectrum with 500 ms DARR 
mixing17,18 was collected. In this spectrum, a specific correlation between a resonance at 
approximately 100.8 ppm and 23.7 ppm was observed (Fig. 6.5a). In the molecule, carbon 13 
and carbon 1’ are the only two carbons that have a resonance of approximately 100 ppm (13A: 
100.5 ppm; 13B: 100.7 ppm; 1’A: 100.9 ppm; 1’B: 100.8 ppm) and carbon 40 is the only carbon 
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to have a resonance near 24 ppm (23.7 ppm in the A state and 23.5 ppm in the B state). In a 
single molecule of AmB, the distance between carbon 13 and carbon 40 or carbon 13 and carbon 
1’ would be a distance of over 20 Å since these carbon sites are located at opposite ends of the 
molecule and would not result in a cross peak. Thus, a crosspeak at 23.7 ppm in ω1 and 100.8 
ppm in ω2 would have to be an intermolecular correlation between carbon 40A and either carbon 
13B or 1’B as structurally depicted in Fig. 6.5b. 
Additionally, other cross peaks in the same spectrum show correlations between carbon 
39A to carbon 13B/1’B, carbon 39A to carbon 17B, and carbon 40A to carbon 17B (Fig. 6.5a). 
Likewise, these interactions cannot be explained by a correlation in a single molecule and show 
an intermolecular contact between the ends of the two states. Though further investigation is 
needed to resolve these distances as well as the molecular packing of the different states of AmB, 
this preliminarily shows that the two states of AmB are correlated at opposite ends and that AmB 
may form an antiparallel homodimer. 
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6.6 Figures and Table 
 
Fig. 6.1. Sample preparation of the AmB aggregate. (a) Structure of amphotericin B. (b) Schematic of the sample 
preparation procedure for SSNMR studies and (c) representative UV-Vis spectra indicating homogeneous and 
heterogeneous states of AmB. (d) Representative 13C CP1D of homogeneous AmB aggregate. Spectrum was 
collected at 600 MHz 1H frequency with an MAS rate of 12.5 kHz and the variable temperature set at 0 ºC. The 
spectrum was signal average for ~46 hours and was processed with 20 Hz line broadening. 
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Fig. 6.2. Chemical shift assignments of the aggregated AmB reveal two states. (a) 13C-13C two-dimensional one-
bond correlation spectrum using SPC7 mixing16 with q = 42. Spectrum was collected at 600 MHz 1H frequency and 
was signal averaged for ~28 hours. Spectrum was processed with 30 Hz line broadening. Labeled in black are peak 
assignments for state A and peak assignments for state B are labeled in blue. (b) Close up view of the same spectrum 
as part a showing a backbone walk of the polyol region for both state A and state B starting from the carbon 9-8 
resonance. (c) Chemical shift differences between state A and state B mapped onto the structure. Sphere sizes 
represent the magnitude of the difference. 
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Fig. 6.3. Cross polarization 13C one-dimensional spectra collected at (a) 0 ºC, (b) 10 ºC, (c) 20 ºC, (d) 30 ºC, and (e) 
37 ºC. The spectra reveal that the populations of two states in the sample are independent of temperature and the two 
states are stable at all temperatures within this range. When the spectra are overlaid (f), no significant differences are 
observed. Spectra were collected at 600 MHz 1H frequency and was processed with 10 Hz of line broadening. Each 
spectrum took ~15 minutes to collect. 
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Fig. 6.4. Carbonyl region of direct polarization 13C one-dimensional spectra collected at (a) 0 ºC, (b) 10 ºC, (c) 20 
ºC, (d) 30 ºC, and (e) 37 ºC. The spectra confirm the temperature independence of the population of the two states 
and the overlay (f) show minor differences that can be attributed to noise. Spectra were collected at 600 MHz 1H 
frequency and was processed with 10 Hz of line broadening. Each spectrum took ~1.45 hours to collect. 
 96 
 
Fig. 6.5. Intermolecular cross peaks observed between the two states of AmB. (a) Cross peaks between carbons 39 
and 40 of one end of the molecules with carbons 13/1’ and 17 of the other end are observed in a 13C-13C 2D 
spectrum with long mixing (500 ms DARR mixing17,18). In a single molecule, these contacts would be too distant to 
result in a cross peak and can only be described by an intermolecular contact as depicted (b). Spectrum was 
collected at 600 MHz 1H frequency and was signal averaged for ~3.7 days. Spectrum was processed with 30 Hz line 
broadening. 
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Table 6.1: 13C Chemical shifts of the homogeneous AmB aggregate 
Atom State A (ppm) State B (ppm) 
1 175.9 174.0 
2 41.2 45.5 
3 71.3 71.5 
4 44.4 45.6 
5 74.5 78.3 
6 36.0 40.2 
7 33.0 37.4 
8 74.6 76.9 
9 79.9 79.0 
10 41.4 42.8 
11 73.2 72.8 
12 47.3 48.2 
13 100.5 100.7 
14 47.2 45.5 
15 69.4 69.8 
16 61.7 60.5 
17 68.3 68.3 
18 40.2 40.6 
19 83.6 84.2 
34 45.9 46.1 
35 78.8 79.4 
36 43.0 43.0 
37 74.6 72.5 
38 20.6 19.6 
39 13.2 13.0 
40 23.7 23.5 
41 182.9 183.1 
1' 100.9 100.8 
2' 71.1 71.3 
3' 58.0 58.1 
4' 71.5 71.2 
5' 75.3 76.0 
6' 20.0 20.7 
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CHAPTER 7 
An efficient method and device for transfer of semisolid materials into solid-state NMR 
spectroscopy rotors 
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7.2 Abstract 
 The study of mass-limited biological samples by magic angle spinning (MAS) solid-state 
NMR spectroscopy critically relies upon the high-yield transfer of material from a biological 
preparation into the MAS rotor. This issue is particularly important for maintaining biological 
activity and hydration of semi-solid samples such as membrane proteins in lipid bilayers, 
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pharmaceutical formulations, microcrystalline proteins, and protein fibrils. Here we present 
protocols and designs for rotor-packing devices specifically suited for packing hydrated samples 
into Pencil-style 1.6 mm, 3.2 mm standard, and 3.2 mm limited speed MAS rotors.  The devices 
are modular and therefore readily adaptable to other rotor and/or ultracentrifugation tube 
geometries. 
 
7.3 Introduction 
Magic angle spinning (MAS) solid-state NMR spectroscopy (SSNMR) is now a well-
established analytical technique that has been used widely in the field of biomolecular research 
to study the structure and dynamics of many important biological molecules.1,2 With all of these 
studies, sample preparation is a vital component, which often includes development of 
approaches to label molecules with isotopes, at substantial cost of materials and labor. The 
culmination of the sample preparation is an often very delicate transfer of the precious sample 
into the MAS rotor. At this stage, the integrity of the sample and yield of transfer are key design 
criteria. In many biological SSNMR samples, the hydration of the analyte has been shown to be 
an important factor in maximizing the resolution of spectra.3-5 Thus, proper hydration is a critical 
consideration when preparing and packing samples into SSNMR rotors. 
The optimal method for packing a sample depends upon the sample type. Some samples 
can tolerate lyophilization and rehydration, in which case standard methods for packing dry 
powders can be utilized. The sample can then be rehydrated by adding water or buffer directly 
into the rotor prior to sealing. However, this approach often fails to hydrate samples uniformly, 
and the spectral quality is typically not as good with lyophilized proteins as with microcrystals.5,6 
To avoid complications of rehydrating samples in the rotor, it would be preferable to pack the 
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wet, semi-solid sample directly into the rotor. However, many approaches to manipulate such 
samples are complicated by the high viscosity and adhesive properties of the pellets. 
Specifically, hydrated semi-solid materials behave like pastes or gels that are difficult to 
scoop with tools designed for dry powders. The high viscosity also prohibits pipetting 
operations. To address these challenges, customized packing funnels have been developed,7 
enabling samples to be centrifuged directly into the rotors to reduce sample loss. Nevertheless, 
sample loss can still occur upon transfer of the material from the penultimate preparation step 
into the funnel. An alternative method8 achieves packing by transferring material into rotors by 
centrifugation directly from centrifuge tubes, using micropipette tips as funnels. Though this 
method works efficiently for the transfer of samples into larger rotors (e.g. 3.2 mm), it again 
requires multiple transfer steps and is difficult to scale down to smaller rotors, given the 
limitations on the physical robustness of small micropipette tips. 
In this contribution, we present a series of rotor-packing devices suitable for packing soft, 
gel phase samples into Pencil style 1.6 mm, 3.2 mm standard, and 3.2 mm limited speed (thin 
wall) MAS rotors with minimal sample loss. Samples are transferred directly from 200 µL 
ultracentrifuge tubes into rotors using moderate speed centrifugation for the final transfer. The 
device is robust, enabling nearly quantitative transfer into the rotor, and material not transferred 
can be recovered since the parts are inexpensive and chemically resistant. Moreover, the 
modularity of the device allows it to be adapted to different sized rotors and centrifuge tubes 
with minimal modification. 
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7.4 Materials and Methods 
7.4.1 DMPC liposome preparation 
DMPC (Avanti Polar Lipids, Inc., Alabaster, AL) was dissolved in chloroform at 20 
mg/mL in a glass vial. ORO in 1:1 chloroform:ethanol was added to the DMPC mixture at a 
molar ratio of 125:1 DMPC:ORO. The bulk of the solvent was removed using a flow of argon 
and the vial was kept under vacuum overnight to pull off any remaining solvent. 
HBS-100 buffer (20 mM HEPES, 100 mM NaCl, 0.02% sodium azide, pH 7.5) heated to 
~42 ºC was added to the dried lipid film such that the final concentration of lipids were 
approximately 1.76 mg DMPC/mL. The solution was then shaken for 1 hour at 37 ºC, 200 rpm to 
homogenize the solution. The cloudy suspension was then bath sonicated for at least 30 min., 
until the solution turned transparent. The solution was then stored at 4 ºC until the sample was 
pelleted. 
The liposomes were initially pelleted in 3 mL ultracentrifuge tubes in a TLA 100.3 
centrifuge rotor (Beckman Coulter Item No. 349481) at 240,000 x g for 4 hrs, 8 ºC. The 
supernatant was removed immediately and the pellets were resuspended in a small volume of 
HBS-100 and transferred to 200 µL ultracentrifuge tubes and were spun down in a TLA-100 
centrifuge rotor (Beckman Coulter Item No. 343840) at 220,000 x g for 2 hrs, 8 ºC right before 
packing. 
7.4.2 NMR data collection 
 Data collection of the 1.6 mm fast MAS sample was done on a 750 MHz 1H frequency 
Varian VNMRS spectrometer equipped with a triple resonance 1H/13C/15N 1.6 mm fast MAS 
probe configured in double resonance 1H/13C mode. Pulse widths for 1H and 13C were 1.75 µs 
and 1.6 µs respectively and SPINAL-64 decoupling9 was used at ~97 kHz. MAS was set to 33 
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kHz and the variable temperature was set at 0 ºC. A pulse delay of 6 s was used and 4,096 scans 
were collected. 
Data collection of the samples in 3.2 mm rotors were done on a 600 MHz 1H frequency 
Varian Infinity Plus spectrometer equipped with a triple resonance 1H/13C/15N 3.2 mm Balun 
probe. Pulse widths for 1H and 13C were 2.3 µs and 2.6 µs respectively and SPINAL-64 
decoupling9 was used at ~80 kHz. MAS was set to 10 kHz and the variable temperature was set 
at 0 ºC. A pulse delay of 6 s was used and 4,096 scans were collected. 
In all cases, chemical shifts were referenced externally to adamantane (downfield peak 
set to 40.48 ppm).10 Spectra were processed using NMRPipe11 or VnmrJ 3.2. 
 
7.5 Results and Discussion 
7.5.1 Design of device 
Three rotor-packing devices (RPDs) were designed to pack hydrated, gel phase samples 
into 1.6 mm, 3.2 mm standard wall, and 3.2 mm limited speed (thin wall) Pencil-style MAS 
rotors directly from 200 µL ultracentrifuge tubes. As shown in Fig. 7.1, these devices are 
comprised of 4 parts (A, B, C, D) that machined out of polychlorotrifluoroethylene (PCTFE, also 
known as Kel-F) and screwed together as an assembly. 
The final step of the sample preparation prior to packing typically is a precipitation or 
pelleting step by ultracentrifugation.  Thus samples are pelleted in 200 µL ultracentrifugation 
tubes (Fig. 7.2a). Then the first step of assembly is to secure the rotor with pieces C and D (Fig. 
7.2b), which make up the rotor chamber. The rotor chamber consists of two separate pieces in 
order to minimize the material loss and readily enable cleaning of all surfaces that might 
encounter overflow of sample. 
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The second step of the assembly is to screw Piece B into the rotor chamber such that the 
tip of the funnel is securely inserted into the rotor. The third step is to place the ultracentrifuge 
tube upside down into the funnel piece (Fig. 7.2c) and to secure the tube with Piece A. The 
whole assembled apparatus—consisting of Pieces A, B, C and D, the NMR rotor and the 
ultracentrifuge tube—is then placed in a 15 mL conical centrifuge tube (Fig. 7.2d) and is spun in 
a swinging bucket centrifuge at approximately 3,000 g, allowing the material to flow from the 
centrifuge tube down through the funnel into the rotor. Detailed schematics with dimensions can 
be found in Fig. 7.3. 
Since the RPDs are made of PCTFE, which has a density12 of approximately 2.1 g/cm3, 
balancing the RPD with water in the centrifugation step of packing is suboptimal, as the shape of 
the RPD and the difference in densities between PCTFE and water can cause strain on the 
centrifuge rotor. Thus, a balance piece (Fig. 7.4) was made. This piece is simply a rod of PCTFE 
of similar shape and size as the RPD with a hollow center. The mass of the piece is slightly less 
than the mass of the 1.6 mm RPD and is supplemented with small amount of water to achieve 
final balance of the two tubes. A single balance piece is suitable for all three RPD models. The 
schematic of the balance piece is in Fig. 7.5. 
The RPD design allows for the packing of samples directly from centrifuge tubes into 
MAS rotors efficiently. Since the tip of the funnel piece fits directly into the rotor, the majority 
of the sample will flow directly into the rotor, and the excess will be contained within the device.  
The use of PCTFE is a critical aspect of the RPD. The low surface tension of the material13 limits 
the amount of material that can stick on the tools. The chemical stability of PCTFE14 also allows 
the device to be compatible with many types of samples. Furthermore, one can easily recover 
samples from the device by rinsing it with a solvent of choice. 
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7.5.2 Test packing using liposomes 
To test the efficacy of the RPD and packing method, samples of natural abundance 1,2-
dimyristoyl-sn-glycero-3-phosphocholine (DMPC) liposomes containing oil red O dye (ORO) 
were prepared (see Materials and Methods Section).  A 30.7 mg pellet, 19.9 mg pellet, and a 8.4 
mg pellet (gravimetric mass) were made to pack a 3.2 mm thin wall rotor, 3.2 mm standard wall 
rotor, and a 1.6 mm rotor fast MAS rotor respectively (Fig. 7.6).  
Table 7.1 summarizes the amount of material transferred in each rotor as well as the mass 
of lipids in each sample, determined through quantitative 13C NMR (Fig. 7.6) and the 
approximate hydration levels that were determined by one-dimensional 1H spectra (Fig. 6.7). 
This confirms that the rotor-packing was successful in transferring hydrated liposomes into each 
type of rotor.  
 
7.6 Conclusion 
The packing of hydrated, semi solid samples into MAS rotors for solid-state NMR has 
been greatly simplified using a newly developed rotor-packing device. The device allows for the 
efficient packing of samples into the rotor directly from a 200 µL ultracentrifuge tube. Three 
distinct designs have been made for different sizes of Pencil-style rotors and can serve as a 
prototype for RPDs of other types of MAS rotors. 
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7.7 Figures and Table 
 
Fig. 7.1. The rotor-packing device is made of four threaded parts (a) and are screwed together (b). The four parts are 
the top piece, funnel piece, rotor chamber, and bottom piece. The device is designed to pack samples directly into a 
Pencil-style MAS rotor from an inverted 200 µL ultracentrifuge tube (c). 
 
 
Fig. 7.2. To pack a rotor using this device, the sample must first be pelleted in a 200 µL ultracentrifuge tube (a). 
Pieces C and D create a chamber where the rotor is secured (b) and piece B is screwed on. The inverted 
ultracentrifuge tube is placed directly into piece B (c) before it is capped and placed directly into a 15 mL conical 
centrifuge tube (d). The entire apparatus is then spun in a swinging bucket centrifuge at approximately 3,000 x g. 
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Fig. 7.3. Detailed schematic of the different components for the RPD. The top piece (a) and bottom piece (d) are 
constant between all three models whereas the funnel piece (b) and rotor chamber (c) differ depending on the size of 
the rotor. 
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Fig. 7.4. Side view (a) and top view (b) of the balance piece used to balance the centrifuge. The piece is 
geometrically similar to RPD and fits into a 15 mL conical centrifuge tube, where a small amount of water is added 
to balance the RPD. 
 
 
Fig. 7.5. Detailed schematic of the RPD balance. 
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Fig. 7.6. Image of the pellet and rotor of as well as the one-dimensional direct polarization 13C NMR spectra of the 
DMPC:ORO samples: (a) 3.2 mm thin wall; (b) 3.2 mm standard wall; (c) 1.6 mm fast MAS. Data collection of the 
3.2 mm rotor samples was done at 600 MHz 1H frequency, 10 kHz MAS. Data collected on the 1.6 mm rotor sample 
was done at 750 MHz 1H frequency, 33 kHz MAS. 4,096 scans were taken for each spectrum with a short refocusing 
echo and 6 s pulse delay. 
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Fig. 7.7. One-dimensional 1H NMR spectra of the DMPC:ORO samples in a (a) 3.2 mm thin wall, (b) 3.2 mm 
standard wall, and a (c) 1.6 mm fast MAS. 32 scans were collected for each spectrum and was processed with 20 Hz 
line broadening.  
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Table 7.1: Mass of material in rotors 
Rotor Type Pellet 
Mass 
(mg) 
Total Mass 
Transferred to Rotor 
(mg) 
Transfer 
Yield (%) 
Hydration 
Level (%) 
3.2 mm Thin Wall rotor 30.7 29.4 96 80 
3.2 mm Standard Wall rotor 19.9 17.2 86 90 
1.6 mm mm 8.4 8.0 95 85 
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CHAPTER 8 
Conclusions and Outlook 
 
8.1 Membrane Localization Domains 
8.1.1 Conclusion of membrane localization domains 
 The structures in solution of the membrane localization domains of Pasteurella multocida 
toxin and Ras/Rap1 specific endopeptidase were determined to be 4-helix-bundle motifs (chapter 
2), confirming the previously predicted secondary structures.1,2 The structures of the two proteins 
were compared with each other but were also compared to the crystal structure3 of the PMT 
(PDB ID: 2EBF) with good agreement, with the greatest differences in the loop regions. 
Therefore, it was concluded that MLDPMT and MLDRRSP are structurally homologous. 
Furthermore, the structures correlated to the 4HB motifs observed in the crystal structures of 
other bacterial toxins containing the homologous domain.3-7 It was also determined that the 
solution structures of the MLDs were in contrast to the crystal structure of MLDRRSP (PDB ID: 
4ERR), indicating that the crystal structure may either represent a state of the protein when it 
interacts with the membrane or may have structural alterations that arise from the crystallization 
conditions and intermolecular packing effects. 
 Since the domains were determined to be 4HBs in solution, it suggests the importance of 
this motif for membrane localization. Alternatively, the MLDs may also undergo a structural 
change when associated to the membrane. Since the structures of the membrane-associated 
proteins have not been studied, the exact interaction is yet to be determined. To understand the 
mechanism of membrane localization and the broader function of MLDs, the structures of the 
membrane-associated state would need to be determined. Specifically, the conditions that favor 
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membrane localization must be investigated, which would lead to a sample to study by solid-
state NMR spectroscopy. 
8.1.2 Determine membrane binding conditions quantitatively 
 Previous work by Geissler, et al.8 showed that 4HB bind to membranes containing 
negatively charged lipids. Furthermore, based on structural models, the authors suggested that 
basic-hydrophobic residues in loop 1 and loop 3 of the MLD are associating with the membrane. 
To determine this, the structure of the membrane bound state of the MLDs can be determined 
using SSNMR. However, prior to performing SSNMR experiments, a sample preparation 
method to properly bind the protein to a membrane mimetic would be necessary. 
The first step would be to determine the binding constant9 of both MLDs to a membrane 
mimetic. This can be performed using both surface plasmon resonance10 as well as isothermal 
titration calorimetry.11  Membrane mimetics, such as liposomes or nanodiscs,12,13 can be 
prepared with a mixture of different lipids. POPC liposomes should be used as a negative 
control, since neither MLD has been shown to localize to POPC alone.8,14 Then, a series of 
membranes containing other lipids, such as POPE, POPG, and POPS at varying concentrations 
should be tested to screen conditions where the MLD exhibits the greatest level of binding. The 
binding constants can then be determined for each protein to each membrane composition. This 
will be a quantitative measure of how tightly the proteins localize to membranes. If a condition 
where the MLD is tightly bound to the membrane is found, SSNMR samples can be made and 
the structure of the membrane bound state can be pursued. 
8.1.3 Solid-state NMR of the membrane bound state of MLDPMT and MLDRRSP 
 SSNMR samples should be prepared with the membrane composition where the MLDs 
exhibit the greatest binding. These samples can then be used to collect standard chemical shift 
 117 
determination experiments, such as 13C-13C 2D spectra with SPCn15,16 or DARR17,18 mixing or 
three dimensional 15N-13C-13C and 13C-15N-13C correlation spectra (NCOCX,19 NCACX,19 
CANCO20). TALOS-N calculations21 can be used to determine the secondary structure of the 
proteins and distance measurements22,23 can be made. Simulated annealing structure calculations 
can be performed using XPLOR-NIH,24,25 which would report on the structure of the membrane 
bound state of the MLDs. 
 In addition to the membrane bound structures of the MLDs, the position of the protein 
with respect to lipid bilayer can be probed using paramagnetic relaxation enhancement 
measurements26 and with water/lipid correlations.27,28 In these experiments, can measure 
distances from the center of the membrane as well as the surface of the membrane to the protein. 
Thus, one can measure the depth of insertion of the residues in the protein into the membrane, 
which would report on the overall interaction of the protein to the membrane. 
 
8.2 Amphotericin B 
8.2.1 Conclusion on amphotericin B 
 Towards solving the structures of the amphotericin B aggregate by solid-state NMR 
spectroscopy, a number of improvements in the area of sample preparation have been made. The 
first was an improvement in the expression and purification of isotopically 13C labeled AmB. 
The new method includes improved protocols of expression using glycerol stocks of S. nodosus 
cultures, DMSO extraction of AmB from cultures, and an MPLC purification procedure. This 
process has prevented failed expressions and has improved the yield of the expression process. In 
addition to improving the production of isotopically labeled AmB, we have surveyed different 
sample preparation methods and developed a sample preparation that yields a homogeneous 
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AmB aggregate that is stable at higher temperatures (37 ºC) and provide excellent SSNMR data. 
Furthermore, rotor-packing methods have been improved ensuring the proper transfer of 
expensive samples into SSNMR rotors for data collection. 
 In the homogeneous AmB sample, 13C chemical shift assignments were made for all 
carbons throughout the molecule, excluding the degenerate polyene carbons. In this analysis, two 
sets of chemical shifts were found, indicating that AmB adopts two unique conformations in the 
aggregate. Preliminary analysis also indicated that the two conformations are forming an 
antiparallel dimer.  
8.2.2 Solving the structure of the AmB antiparallel dimer 
 The improvements in sample preparation have enabled the collection of new, high 
resolution SSNMR data on AmB and have revealed new insights on the structure of the AmB 
aggregate. The first objective of the project will now be to determine the structure of AmB 
antiparallel dimer. 
 Using the chemical shift assignments of the two conformations (reported in chapter 6), 
structure calculations using density functional theory29,30 are being actively pursued to determine 
the structures of the two conformations. Results so far have yielded two unique polyol 
conformations, where the calculated chemical shifts agree well with the experimental chemical 
shifts (Alex Greenwood, unpublished results). 
 To further refine the models of the AmB structure, chemical shifts of the all the carbons 
throughout the molecule should be assigned. However, the chemical shifts of the polyene 
carbons have not previously been unique assigned because of the spectral degeneracy observed 
in this spectral region of both solution and solid-state NMR spectra. One could potentially 
determine the chemical shifts of the polyene carbons using a skip-13C labeled AmB sample. A 
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skip-13C labeled AmB sample, which is expressed with 1-13C-glucose and is 13C labeled at only 
certain carbon sites in the molecule (Fig 8.1), has been prepared. Among the major advantages of 
the skip-13C AmB sample would be the greater resolution in the polyene region since only every 
other carbon is labeled, similar to results seen by glycerol labeling in protein NMR.31 
Furthermore, the decreased number of labeled carbons yields fewer peaks in the polyene region, 
decreasing the spectral degeneracy. 
 Using this fractionally labeled molecule and further diluting the sample in a background 
of natural abundance (50%), a 13C-13C-13C three-dimensional correlation spectrum32,33 could be 
collected to determine intramolecular correlations between polyol carbons and polyene carbons.  
By using short DARR mixing periods, correlations such as C10 to C22, C8 to C24, and C4 to 
C28 could be determined. If no differences in the polyene carbon shifts are observed between the 
two states of AmB, we would then be able to conclude that the polyene chain does not exhibit 
differences between the two states. 
 Parallel to determining the conformations of the two states, more long-range contacts 
between the two conformers must be determined. As mentioned in chapter 6, a few 
intermolecular contacts between the two states were determined with U-13C AmB samples. 
Currently, distance data is being collected with a skip-13C AmB sample and are revealing more 
intermolecular cross peaks between the two states of the molecule. The crosspeak intensities can 
then be correlated to interatomic distances and can be used for distance restraints in structure 
calculations.22,23 Furthermore, 1H detected experiments could also be used to further determine 
distances at the interface of the two states.34-37 
 Finally, simulated annealing structure calculations using XPLOR-NIH24,25 should be 
performed on AmB. These calculations will incorporate the structural models of both states of 
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AmB along with the distance restraints, yielding a structure of the AmB dimer complex in the 
absence of sterols or lipids. This would then serve as a new structural model of AmB for future 
studies, including the study of AmB-sterol complexes. 
8.2.3 AmB-ergosterol complex structure determination 
 AmB kills fungal cells by binding to ergosterol.26,38 In previous studies, the AmB-Erg 
complex was studied and chemical shift perturbations between free Erg and Erg when bound to 
AmB were determined.26 However, the structure of AmB bound to sterol has yet to be 
determined but would be critical in understanding the pharmacology of AmB. One of the 
challenges encountered in the past was the lack of resolution of AmB in the SSNMR spectra. 
Given the advancements in sample preparation of AmB sample, a new sample preparation of the 
AmB-Erg complex is currently being developed. Using this sample preparation, a number of 
different samples using a variety of isotopically labeling patterns of AmB and Erg will be made. 
Currently in the Rienstra and Burke groups, Erg can be expressed with three different isotopic 
labeling patters (U-13C, 1-13C-acetate, 2-13C acetate) in addition to commercially available NA 
Erg (Fig 8.2). 
 With higher resolution, chemical shifts of the AmB in the presence of Erg can be 
determined. By preparing a sample with U-13C AmB with excess NA Erg, data sets similar to the 
13C-13C 2D data sets, similar to the data presented in chapter 6, can be collected. Chemical shift 
perturbations between the free state and bound state of AmB will report on the differences that 
AmB experiences in the presence of Erg. One hypothesis of AmB bound to Erg would be that 
AmB adopts one of the two conformations that were observed in the dimer. A second hypothesis 
would be that AmB remains as an antiparallel dimer and that an Erg molecule is in the center of 
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the dimer. A third outcome may be that AmB bound to Erg forms a completely new 
conformation.  
 Once chemical shift assignments are made, distances between AmB and Erg should be 
measured. Since the chemical shifts of bound AmB have not yet been determined, it is unclear 
which carbons in AmB would be resolved from carbons in Erg. However, there are a few 
carbons between AmB and Erg that should be resolved. For example, carbon 7 of bound Erg has 
a resonance of 120 ppm, which should be resolved from all peaks in AmB. Likewise, the 
carbonyls of AmB should be resolved from Erg since Erg contains no carbonyls and has no 
resonances above 150 ppm. 
 Similar to solving the sterol free structure of AmB, XPLOR-NIH calculations24,25 should 
be performed on the AmB-Erg complex. Furthermore, this process whole process could be 
repeated to study the structure of AmB-cholesterol complex. This would lead towards 
understanding the structural underpinnings of AmB-sterol binding and the reasons for the 
variation is activity differences of AmB with sterols. 
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8.3 Figures 
 
 
Fig. 8.1. Structure of AmB indicating the 13C labeling pattern when expressed with 1-13C glucose. Red spheres 
indicate labeled carbons. 
 
 
 
Fig. 8.2. Structures of Erg indicating the 13C labeling pattern when expressed with 1-13C acetate (yellow spheres), 
and 2-13C acetate (red spheres). Every carbon is labeled when Erg is expressed with U-13C acetate. 
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